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Human iodotyrosine deiodinase (hIYD) belongs to nitro-FMN reductase 
superfamily and is responsible for recycling iodine from the I-Tyr 
(monoiodotyrosine) and I2-Tyr (diiodotyrosine) formed as byproducts of thyroid 
hormone synthesis. Heterologous expression of hIYD lacking its membrane 
domain in E. coli provided large quantities of highly pure hIYD that allowed for 
its physical and biochemical studies. Its kinetic parameters, binding constants and 
crystal structure were characterized. Substrate was able to induced dramatic 
effects on FMN coordination in hIYD, including the zwitterionic region of I-Tyr 
interacts with the N3 and O4 of the FMN, the OH of Thr239 moved close to N
5 
of 
FMN (from 4.8 Å to 3.1Å) and allowed the formation of a hydrogen bond. The 
aromatic ring of I-Tyr additionally stacks above the FMN. Accumulation of the 
neutral semiquinone was observed during the reduction of hIYD in the presence 
 
 
of substrate analogue 3-fluoro-L-tyrosine (F-Tyr). In the absence of ligand, only 
the oxidized and two-electron reduced forms of FMN were observed. Among all 
of the interactions to FMN in hIYD, H-bonding at the N5 FMN was identified as 
most important to control the redox of flavin. Mutagenesis of Thr239 to Ala 
removed this H-bonding as confirmed by the crystal structure of hIYDT239A•F-
Tyr. As a result, no semiquinone was detected during the titration of hIYDT239A 
in the presence of F-Tyr. The deiodination activity of T239A was also 
dramatically decreased (10-fold).  
The zwitterion region of the substrate was found critical for binding to 
enzyme. Modifications of the zwitterion region resulted in at least a 500-fold 
increase in KD. The catalytic activity was unlikely determined by the zwitterion 
region since all of the modified substrates exhibited similar initial rates as the 
native substrate under conditions in which their concentration equaled their KD. 
The pH dependence of hIYD binding indicated that the phenolic group of I2-Tyr 
is also critical for binding and the hIYD prefers binding to the phenolate form of 
substrate. All the results presented in this thesis support the current proposed 
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Chapter 1: Introduction 
1.1 The function of IYD  
1.1.1 Iodine is an essential element required for thyroid hormones. 
The thyroid hormones, triiodothyronine (T3) and thyroxine (T4) made by 
the thyroid gland are important for regulation of the body, including the rate of 
our metabolism, the speed of our heartbeat, our body temperature, muscle strength 
and the rate of replacing dying cells (1, 2). Iodine is an essential element required 
for the synthesis of T3 and T4 (Figure 1-1).  Iodine is relative scarce in the topsoil 
of the earth. Most iodine (as iodide) is stored in ocean. Iodine from the seawater 
evaporates into the atmosphere and returns to the soil and groundwater by rain. 
The cycle of iodine in inland regions and mountainous areas is slow and 
incomplete. Population depending on food from these areas have insufficient 
iodine intake. Around 2 billion individuals live in iodine deficient areas, such as 
south Asia and sub-Saharan Africa (3). 
1.1.2 Iodine deficiency  
Iodine deficiency has multiple adverse effects on growth and development 
in human termed iodine deficiency disorders (IDD). Goiter and hypothyroidism 
can occur of all ages and are the classic of iodine deficiency. Severe iodine 
deficiency during pregnancy causes serious damage to the fetus and may result in 
abortion, mental retardation, stillbirths and congenital abnormalities (3). For child 
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and adolescent, IDD is reported as impaired mental function and delayed physical 
development. The intelligence quotient (IQ) of children suffering severe iodine 
deficient was reported to be 12 points on average lower than children from iodine-
sufficient areas (4-6). Moderate iodine deficiency in adults may lead to reduce 
work productivity resulting in impaired social and economic development (6). 
The prevalence of severe iodine deficiency was reduced during the past 25 years 
by introducing iodized salt. Thirty countries remain iodine-deficient (9 are 
moderately and 21 are mildly) until 2013 (7). 
 
Figure 1-1. Thyroid hormones (T3 and T4) and the byproducts monoiodotyrosine 
(I-Tyr) and diiodotyrosine (I2-Tyr) during hormones synthesis. 
 
 
1.1.3 Iodotyrosine deiodinase is critical for iodine recycling 
Adequate production of thyroid hormones is not only depended on the 
daily ingestion of iodine, it also requires the efficient recycling of iodine from I-
Tyr and I2-Tyr produced during thyroid hormones synthesis. Iodide is transported 




 symporter (Figure 1-2) (8). Iodide is 
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then oxidized and coupled to tyrosyl residues of thyroglobulin in colloid by 
thyroid peroxidase. The resulting mono- and diiodinated tyrosyl residues of 
thyroglobulin undergo further coupling to form T3, T4 and forming byproducts I-
Tyr and I2-Tyr (9).  Approximately seven I-Tyr and six I2-Tyr are formed for 
every T4 synthesis (10).  Release of T3/T4 into the plasma is under the regulation 
of thyroid-stimulating hormone. T3 is 10-fold more active than T4 in regulating 
metabolism (11). A thioredoxin superfamily protein-iodothyronine deiodinase is 
responsible for converting T4 to T3, which also contributes to iodide recycling. 
However, the primary mechanism for iodide recycling is salvaging the iodide 
from the excess I-Tyr and I2-Tyr catalyzed by iodotyrosine deiodinase (IYD). 
Failure of IYD’s activity termed as iodotyrosine deiodinase deficiency (ITDD) 
causes excess I-Tyr and I2-Tyr to be released into the bloodstream that finally 
leads to severe loss of iodide. The first type of ITDD was recognized in 1953, 
when patients shown spontaneous release of iodotyrosines from the gland after 
uptake 
131
Iodide (12, 13). Stanbury et al later detected an abnormal increase of 
iodotyrosines from patient with congenital goiter and hypothyroidism in 1955 
(14). Until 2014, ITDD has been identified in more than 25 family pedigrees with 
various conditions range from simple goiter to severe hypothyroidism with mental 




Figure 1-2. Iodide metabolism process in thyroid follicular cells (9).   
 
1.1.4 Molecular level analysis on IYD deficiency 
In 2002, serial analysis of gene expression to human thyroid tissue 
identified the hIYD gene DEHAL1, which is organized in six exons spanning over 
35 kb on human chromosome 6p24, up-regulated by TSH-stimulated cAMP and 
down-regulated by iodide (16, 17). Alternative splicing of exon 5 results in 
several isoforms of DEHAL1, the most abundant isoform in thyroid is isoform A 
encoding active IYD. Isoforms B and C from the inclusion of exon 5 and a 3′-
extension of exon 5 were inactive (18). The N-terminal domains of the three 
isoforms are similar. However, the C-terminal domain, which is critical for the 
deiodination activity, is different. Most hIYD is present in the thyroid. Other 
organs, liver, kidney and trachea also have low levels of hIYD  (9, 17).  
 Identification of DEHAL1 leads to the evolution of ITDD screening to 
molecular level. hIYD mutations were reported in 2008 in patients with severe 
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goitrous hypothyroidism and abnormal I2-Tyr level from unrelated families living 
in different countries (19). These mutations include mutants R101W and I116T 
and a deletion of three residues F105-I106L. An additional mutant A220T was 
also reported in two consanguineous families from Morocco with severe 
hypothyroidism and goiter (20). Further analysis on these patients indicates that 
the severity of ITDD also depend on environmental factors (iodine intake).  
1.1.5 Screening for ITDD  
The prevalence of ITDD may be more common than thought since 
patients harboring IYD defects may be undetected by current screening programs 
for congenital hypothyroidism due to the lack of biochemical expression of the 
disease at the early age of life. Delayed diagnosis of ITDD may lead to severe 
mental retardation later in life. Using I-Tyr/I2-Tyr as biomarkers gives the 
potential to improve the pre-clinical detection of IYDD during the neonatal time. 
Radio-immunoassay was shown capable to determine I2-Tyr in serum and urine 
(19).  A new generation of sensitive antibodies against IYD and a defined 
population-based reference may be required for development of this method for 
ITDD detection. Another useful technique, HPLC-MS, accurately distinguished 
normal from elevated I-Tyr/I2-Tyr serum/urine levels although this technique is 
highly cost and poor in clinical settings (20, 21). 
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1.1.6 Function of IYD beyond thyroid hormone synthesis  
IYD appears in a wide range of organism, including honeybee, lancelet, 
daphnia, zebrafish, sea anemone and bacteria, and all behave as reductive 
deiodinases for I2-Tyr (22). The function of iodide derivatives in lower organisms 
is still unknown. The physiological role of IYD in diverse organisms not 
associated with iodide digestion may imply a function of IYD beyond iodide 
recycling for hormones synthesis. A recent investigation on the expression pattern 
of IYD during chick ontogeny indicates that IYD present in different components 
of the chick embryo, suggesting IYD might be involved in regulating cell specific 
deiodination of I-Tyr and I2-Tyr prior to the formation of functional thyroid (23). 
The Caenorhabditis elegans IYD ortholog was suggested important for the 
metabolic state of muscle cells by using NADH as a coenzyme to activate the K
+
 
channel associated with muscle membranes (24). 
1.2 The flavoenzyme 
1.2.1 IYD is an unusual flavoprotein 
In 1969, Rosenberg and Ahn investigated the effects of flavins (FAD, 
FMN and riboflavin) on the I2-Tyr deiodination activity of IYD and found that 
IYD’s activity is largely depended on flavin, suggesting IYD as a flavoprotein (25) 
(Figure 1-3). 10 years later, IYD from bovine thyroid was partially purified and 
flavin mononucleotide (FMN) as its cofactor was identified (Figure 1-3) (26, 27). 
Flavoproteins serve a wide range of biological and chemical process, including 
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electron transfer, bioluminescence, reduction and oxidation, halogenation, 
photosynthesis and more (28, 29). However, dehalogation has only been reported 
in few flavoprotein. Anaerobic organisms commonly adopt reductive 
dehalogenation. Based on our current knowledge, only two other enzymes, 
iodothyronine deiodinases D1 and tetrachlorohydroquinone dehalogenase were 
suggested catalyzing reductive dehalogenation (9). A flavoprotein performing 
reductive dehalogenation under aerobic conditions is very unusual.  
 
Figure 1-3. The catalytic reaction of IYD. 
 
1.2.2 Flavoprotein in human 
According to a recent analysis, 90 genes within the human genome encode 
flavin-dependent proteins using either FMN (12) or flavin adenine dinucleotide 
FAD (64) or both (5) (30). 90 % of the human flavoproteins non-covalently bind 
to FMN or FAD. Others may covalently bind between the 8-α-methyl of flavin 
and His or Cys residue of protein. More than half of the human flavoproteins 
structures have been solved. The structures of many membrane-associated human 
flavoproteins are still unavailable. The majority of human flavoenzymes involved 
in cofactor biogenesis and metabolism, including folate and cobalamin 
metabolism, biosynthesis of heme, pyridoxal 5’-phosphate, Coenzyme A, 
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Coenzyme Q, steroid, thyroxine and iodine salvage. Flavoproteins also partner 
with other flavoproteins. For example, two FAD-dependent proteins, ACAD9 and 
FOXRED1 have been shown to be critical for the assembly and activity of 
complex I responsible for human respiratory electron transport (31). 
Flavoenzymes are also closely associated with certain human diseases. According 
to the records in OMIM, around 60 % of human flavin-dependent proteins have 
been reported associated with human disorders, including dysfunctions in 
mitochondrial processes and abnormal metabolic pathways (30). Considering the 
important roles of flavoproteins in human, determination of their structures as 
well as fully characterization of their catalytic mechanisms is certainly 
encouraged.  
 




1.2.3 The redox states of flavoproteins 
The biochemical function of flavoprotein is largely depended on its FMN 
or FAD. By adding hydrogen atoms to the nitrogen atoms on the isoalloxazine 
ring (Figure 1-4), oxidized FMN or FAD can be reduced to its one-electron-
reduced state (semiquinone) or fully reduced state (hydroquinone) via one-
electron reduction or two-electron reduction (Figure 1-5) (29, 32). They can easily 
be distinguished by optical spectroscopy. The oxidized flavin is yellow and 
exhibits a maximum absorbance around 450 nm. The pKa of N1 and N3 of 
oxidized isoalloxazine ring are 0 and 10, respectively (28). Once reduced to the 
semiquinone form, the protonating/deprotonating at the N5 atom result in two 
different semiquinone forms due to the pKa at N5 is ~ 8.3 (33). The protonated 
neutral semiquinone is blue and has an absorbance around 590 nm. In contrast, 
the deprotonated anionic semiquinone is red and show maximum absorbance 
around 390-410 nm and 480 nm. The fully reduced hydroquinone form is 
colorless and can also exist in neutral or anionic forms under physiological 





Figure 1-5. The redox states of flavin. 
 
1.2.4 Redox control of Flavin 
In flavoproteins, an input signal will cause the redox change of flavin 
followed by a new functional output of the flavoprotein. Substrate binding, 
electron transfer or light-mediated reductions represent the primary input signal. 
In the active site of flavoproteins, the redox control can be realized by H-bonding 
to N5 atoms, H-bonding between protein and N1, N3, O2, and O4 of flavin, 
aromatic stacking, bending of the isoalloxazine ring along N5-N10 axis and 
conformational changes of ribityl chain of flavin as discussed below.  
1.2.4.1 Redox dependent change in the bending angle of isoalloxazine ring 
According to a recent analysis on the crystal structure in PDB (34), for 
oxidized flavins in protein, their isoalloxazine rings mainly adopt planar 
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conformation. However, fully reduced flavins in proteins are likely bend along the 
N5-N10 axis by range from 0° to 34° (34). For most flavoproteins, the bending 
angles are less than 10°. Thioredoxin reductase was observed with the largest 
bending angle of 34° (35). The conformational change of isoalloxazine ring may 
cause by crystal packing instead of redox state change because all the structure 
was in crystal form. Quantum chemical analysis provides support to the 
observation that bending of isoalloxazine ring is redox depended (36). However, 
the conformation change of FMN may largly afftected by the interactions of 
neighboring groups since NMR analysis suggested that the fully reduced flavin is 
intrinsically planar in water (36).  Moreover, some oxidized flavoprotein, such as 
monoamine oxidases, polyamine oxidase and cholesterol oxidase, are also 
reported with bent isoalloxazine ring (34). In some flavoprotein, altering the 
direction of bond connecting the N10 atom and the ribityl chain will result in an 
accumulation of mechanical tension (37). To release the tension, the ribityl chain 
will adopt a conformational change, causing the rearrangement of the hydrogen 
bonding between its three hydroxyl groups and protein.  
1.2.4.2 H-bonding with the N5 atom 
The redox control of flavin frequently involves the N5 position since this 
atom can behave as hydrogen bond donor or acceptor based on its redox state. As 
a redox control, N5 atom could behave in three different types. In first type, a H-
bond forms between the oxidized flavin N5 atom and protein. Reducing the flavin 
results in breaking of this H-bond and induces further conformational changes on 
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protein. For example, breaking of the H-bond between Lys53 and N5 of FAD in 
bacterial ferredoxin reductase was observed under reduced condition and was 
suggested necessary for forming high binding affinity with its partner protein (34, 
38). The second type of N5 redox control was found in flavodoxin. There is no H-
bond for its oxidized state, however, reduction of flavin in flavodoxin induces the 
flip of a peptide bond and enables the H-bonding between the protonated N5 and 
the carbonyl oxygen of the flipped peptide (39). The third type includes the 
rearrangement of H-bond network at N5 and O4 atoms upon light activation, 
which is critical for catalysis. 
1.2.4.3 Aromatic stacking 
Aromatic stacking between the isoalloxazine ring of FMN and aromatic 
residues of the proteins is also important for the redox control of flavoprotein. In 
the flavodoxin, the isoalloxazine ring of FMN is flanked by at least one aromatic 
amino acid residue, such as Tyr 98 of the Desulfovibrio vulgaris flavodoxin (40). 
Elimination of the π- π stacking by mutation of Tyr 98 to Ala produces 
substantially shift on the one-electron reduction potentials, particularly for the 
FMNsq/hq couple. Similarly, Trp1046 in cytochrome P450 reductase BM3 stacks 
over the isoalloxazine ring and an equivalent Trp is conserved across the P450 
superfamily (41). In wild type, a stable blue semiquinone species was observed 
during reductive titration. However, no semiquinone species was detected during 
the titration of W1046H and W1046A mutant (42). Redox potential analysis also 
indicated significant elevation on the redox potential of FMNsq/hq couple. 
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As a flavoprotein, the electron transfer process as well as the redox 
property of flavin in IYD is still not clear. Recent progress on IYD as described 
below improved the understanding on the coordination of FMN and provided a 
structural base for understanding the redox property as well as the redox control 
of FMN in IYD.   
1.3 IYD represents a new subclass within the nitro-FMN reductase 
superfamily 
1.3.1 IYD belongs to nitro-FMN reductase superfamily 
Sequence analysis of mIYD indicates that IYD consists of three domains, 
N-terminal membrane domain (residues 1-24), intermediate domain (residues 25-
85) and C-terminal catalytic domain (residues 86-289) that belongs to the nitro-
FMN reductase superfamily (43). The N-terminal domain was a trans-membrane 
anchor. The structure and function of the intermediate domain is still unknown. 
Deletion of the first 33 amino acid of mouse IYD and expressing the remaining 
gene in Sf9 cells result in pure soluble mIYD (44). The truncated mouse IYD 
retains the deiodination activity with dithionite as reducing reagent. Crystal 
structures of this truncated mIYD with or without substrate I-Tyr were solved 
(44). This protein contains a α-β fold structure typical to nitro-FMN reductase 
superfamily. Two FMN bind the interface of the two swap monomers (Figure 1-
6). Interestingly, substrate binding induces the formation of a helix-turn-helix 
active site lid that covers the FMN and I-Tyr binding site and sequesters the active 
site from solvent (Figure 1-6). The aromatic ring of substrate I-Tyr stacks on the 
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isoalloxazine ring of FMN. The zwitterion region of I-Tyr form H-bonds to the 
N3 and O4 atom of FMN. In the presence of I-Tyr, the OH group of Thr235 in 
mouse IYD moves close to the FMN and form H-bond to the N5 atom of FMN 
(Figure 1-8). The rearrangement of H-bond network of FMN induced by substrate 
binding may significantly influence the redox property of FMN in IYD.  
 
 
Figure 1-6. The crystal structure of mIYD (A) and mIYD•I-Tyr (B). Two 
monomers are shown in magenta and blue. Substrate I-Tyr is shown as green 
stick. FMN is shown in yellow (44).  
 
1.3.2   Highly conserved key residues in IYD homologue 
Successfully expression of the truncated soluble IYD accelerates the study 
of IYD homologous. The IYD homologous from a variety of organism were 
purified and exhibited comparable deiodination activity (within a single order of 
magnitude) with mouse IYD (45). The key residues involved in the substrate 
binding are highly conserved (Figure 1-7), including E153, Y157 and K178, 
which directly interact with the zwitterion region of I-Tyr, and A126, which 
provides interaction to the OH group of I-Tyr (46). Residues responsible for the 
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FMN coordination in IYD are found also highly conserved, such as Thr235 that 
forms interaction with N5 of FMN and Arg 96, Arg 97, Arg 100 and Arg 275 that 
form interaction with the O2 and ribityl chain of FMN. Slightly variation between 
Ser and Thr was found on Ser98, which also involves in ribityl chain interactions 
(45). This finding suggests those key residues may be important for the 
deiodination of IYD.  
 
 
Figure 1-7. Multiple sequence alignment of the catalytic domains of IYD 
homologs. Residues in red (or white) are fully conserved. Key residues 
coordinating to substrate and FMN are indicated with an (*) and (+), respectively. 




1.3.3 IYD and BluB represent a new subfamily  
Within nitro-FMN reductase superfamily, IYD share the most structural 
similarity with a bacterial flavin destructase (BluB, an enzyme using FMN as 
substrate for vitamin B12 synthesis) despite only 19 % sequence identity (44, 47). 
The positions of their active site lid sequence for IYD and BluB are very distinct 
with the other two subfamilies representatives NADH oxidase (NOX) from 
Thermus thermophiles and flavin reductase P (FRP) from Vibrio harveyi (48, 49). 
For IYD and BluB, a region close to the N-terminal forms the active site lid. In 
contrast, the lid for NOX is positioned within the central region of whole 
polypeptide and the lid for FRP is from the C-terminal extension region. This 
difference led to the proposal that IYD and BluB may represent a new subfamily 
of nitro-FMN reductase superfamily (44). The flavin coordination in IYD and 
BluB are also very different with NOX and FRP (Figure 1-8). There are fewer 
interactions between the pyrimidine ring of FMN and active site residues in BluB 
and IYD (44).  H-bond to the N5 atom of FMN in IYD and BluB is derived from 
the side chain hydroxyl group of Thr235 and Ser167, respectively, however, the 
H-bond to N5 position for other superfamily members are commonly from the 
backbone or side chain N-H bonds. As described above, the H-bond network of 
flavin is very important for the redox control as well as the reduction process. 
Thus, the similar H-bond network of isoalloxazine of flavin in IYD and BluB may 





Figure 1-8. FMN coordination in mIYD, BluB and FRP (44).  
 
1.3.4 Proposed mechanism of deiodination by IYD  
The electron transfer of FMN in IYD may proceed through two single-
electron transfer processes with stabilization of the flavin semiquinone or via a 
single two-electron transfer process. The nitroreductase described in nitro-FMN 
reductase superfamily are O2 insensitive and unable to promote single electron 
transfer to reduce O2 (50). In general, they perform two-electron transfer from 
NAD(P)H to the nitro group of nitroaromatic compounds using ping-pong, bi-bi 
kinetic mechanism, and the FMN cycles between oxidized and reduced form by 
two-electron reduction (50). As a member of this superfamily, it was suggested 
that IYD’s mechanism might involve a two-electron transfer process. Especially, 
the catalytic mechanism of two other reductive dehalogenase-
tetrachlorohydroquinone dehalogenase and ID involves a substrate 
tautomerization, keto intermediates formation and subsequent nucleophilic 
reaction by the said chain of Cys or Ser (51, 52). Based on analysis of the 
mechanism of those reductive dehalogenase, the early two-electron transfer 
mechanism for IYD was proposed (53). In this proposal, a sulfenyl iodide will be 
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generated after active site Cys reacts with the tautomeric keto substrate, followed 
by further reducing by flavin and iodide releasing. However, later site-direct 
mutagenesis and structural analysis indicated that Cys residues in IYD are not 
involved in IYD catalysis (54). Moreover, no other amino acids in the active site 
is appropriate for a nucleophilic reaction such as that supported by Cys (46). 
Therefore, the two-electron transfer deiodination proposal for IYD is not 
supported by current evidence.  
In contrast, the neutral flavin semiquinone radical was detected during the 
oxidation of reduced FMN within IYD, although its lifetime of this semiquinone 
(days) is not consistent with the enzyme reaction (44). Observation of 
semiquinone may imply a stepwise single-electron transfer process of FMN in 
IYD. Moreover, BluB, exhibiting the most similarity in FMN coordination with 
IYD in nitro-FMN reductase superfamily, promotes one electron transfer process 
involving O2-dependent degradation of its bound FMN (47). The current proposal 
for IYD’s mechanism involving a stepwise single electron reduction may or may 
not involve the substrate tautomerization as illustrated in Figure 1-9 (9). Fully 









1.4 Specific aims 
IYD from human remains poorly characterized. Over the past decade, 
significant progress have been made on IYD from other organisms providing a 
platform for understanding the redox property as well as deiodination mechanism 
of IYD. The goal of my research was to investigate the catalytic process using 
IYD from human as the model. This dissertation describes the following: 
1) Obtaining highly pure hIYD in large scale by convenient E.coli 
expression for biochemical and biophysical characterization, 
2) Elucidating the possible ionization of residues critical for catalysis 
and binding by pH dependent studies,  
3) Demonstrating the influence of substrate binding to the structure 
and redox properties of IYD by X-ray crystallography and redox 
titration, 
4) Investigating the role of H-bonding between OH group of Thr239 
and N5 of FMN in control of FMN redox and deiodination in 
hIYD by generating T239A and T239S mutants and characterizing 
their structural, redox and kinetic properties,  
5) Illustrating the importance of the zwitterion region of substrate for 
its binding, catalysis and redox control of hIYD by measuring the 




Chapter 2: General characterization of hIYD 
2.1 Introduction 
hIYD is still poorly characterized although cDNA that encodes human 
IYD had been discovered 10 years ago (16). Previous investigation on hIYD had 
been limited to its expression in human embryonic kidney (HEK) 293 cells in 
2004 (17). The fraction of expression identified with hIYD by western blot 
analysis was used for initial biochemical characterization (17). The hIYD fraction 
was shown to require NADPH for deiodination (17). The Vm of deiodination with 
I-Tyr was found 6 times higher than I2-Tyr (0.53 nmol/100 μg/10 min). The Km of 
I2-Tyr was reported as 2.67 µM, which is around two-fold larger than that of I-Tyr 
(1.35 µM) (17). No further kinetic or structure characterization on hIYD has been 
reported after 2004. Considering the importance of hIYD for iodide recycling, 
investigation the hIYD is advantageous for understanding of hIYD related 
disease.  
Sequence analysis allow the identification of the N-terminal trans-
membrane anchor of IYD (43). Truncation of the N-terminal domain of the gene 
from mouse provided a soluble enzyme when expressed in sf9 and P.pastoris (44, 
54). The ability for NADPH to drive catalysis is lost once IYD is removed from 
its native membrane and consequently dithionite is used as reducing reagent for 
most studies in vitro (54). This truncated IYD exhibited similar rate constants to 
that of the wild-type enzyme with dithionite (54).   
Recently, pure soluble IYD from 7 different organisms has been 
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successfully obtained after fusion to a SUMO tag and expression in E.coli (45, 
46). Sumo is an 11 kDa ubiquition-like protein (55). Fusion of protein to sumo 
can largely improve the solubility of the recombinant protein (56-58). Cleavage of 
sumo tag depends on the recognition of the tertiary structure by sumo protein 
protease Ulp1 (59). The digestion is very specific, resulting in production of the 
target protein with no extra residues. Successful expression of IYDs from other 
organisms by using sumo fusion tag and bacterial expression system provided a 
great platform for obtaining a large amount of pure protein for further study on 
IYD from human.  
Success in heterologous expression allows many experiments on the 
catalytic properties of mIYD. The binding property and reactivity of mIYD with 
several substrate analogs such as, 3-monobromotyrosine (Br-Tyr), 3-
monochlorotyrosine (Cl-Tyr), 3-monofluorotyrosine (F-Tyr), Tyr and 3-
methyltyrosine (Me-Tyr) were investigated to understand the role of the 3-
position substituent in substrate specificity (44). Interestingly, the mIYD was also 
found to promote dehalogenation of Br-Tyr and Cl-Tyr. However, no turnover 
was observed with F-Tyr. The KD for Br-Tyr and Cl-Tyr are almost equivalent to 
I-Tyr, demonstrating very tight binding to IYD. The KD for F-Tyr is slightly 
higher (10 fold) than I-Tyr, but still in μM range. The decreased binding affinity 
for F-Tyr seems not correlated with fluorine’s decreased sterics since Me-Tyr, 
which is larger than fluoro substituent, exhibited very poor affinity (KD is over 1.5 
mM). Similar to Me-Tyr, Tyr also shows poor affinity (60). The phenolic pKa of 
Me-Tyr and Tyr are ~10, which is 2 units higher than other halo-tyrosine 
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derivatives with pKa ~8 (61). This result seems consistent with the hypothesis 
described by Green that Tyr derivatives with lower pKa’s binds more tighter to 
IYD (62). Lower pKa means a greater equilibrium concentration of the phenoxide 
anion. Confirmation that the phenolate preferential bind awaits analysis on the 
dependence of substrate’s binding affinity with pH. 
 
 
Figure 2-1. The active site of mIYD•I-Tyr (PDB ID 3GFD). Two monomers are 
shown in green and purple (45).  
 
X-ray crystallographic studies on mIYD revealed that the IYD active site 
residues (Tyr157, Lys178, Glu153, Ala126) directly interact with substrate and 
FMN (Figure 2-1) (44, 45). Their ionizable groups may be critical for binding as 
well as catalytic activity and worth for further investigation. From the pH 
dependence of enzyme catalyzed reaction, it is possible to determine the ionizable 
groups involved in catalysis and may yield a great deal of information on catalytic 
mechanism.  
In this chapter, we first time investigated the expression of truncated IYD 
from human by E.coli system. Successful purification of hIYD on a large scale 
allowed the further characterization of the kinetic behavior of hIYD. To 
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investigate the hIYD’s substrate binding specificity and to rationalize the 
relationship of ligand’s pKa and binding affinity with hIYD, binding affinities of 
hIYD to tyrosine derivatives is measured. pH-rate profile and pH vs KD profile is 
also created to investigate the variations of activity and binding affinity with pH 
to illustrate the ionizable groups that are critial for binding affinity and catalysis.  
2.2 Experimental 
2.2.1 Materials 
DNA primers were obtained from Intergrated DNA Technologies 
(Coralville, IA). OneShot Top10 E.coli was purchased from Invitrogen (Carlsbad, 
CA). Rosetta 2 (DE3) E. coli was from Novagen (San Diego, CA). The pET28-
SUMO vector was obtained from Dr Christopher Lima. Other pET plasmids and 
antibodies were purchased from Novagen. All enzymes were from New England 
Biolabs. All other biochemical reagents were obtained at the highest grade and 
used without further purification unless specified. 
2.2.2 General methods 
PCR reactions were performed in Eppendorf Mastercycler. The amplified 
product and pET28-SUMO vector were digested with BamHI and XhoI. The 
vector was dephosphorylated with Antarctic alkaline phosphatase. The insert and 
vector were then ligated using T4 DNA ligase following the manufacturer’s 
instructions. Transformations were performed with an Eppendorf Electroporator 
2510 (1700 V, 1 mm gap cuvett). Plasmid DNA was isolated from colonies 
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resistant to Kanamycin monosulfate using a GeneJET plasmid miniprep kit 
(Fermentas, Glen Burnie, MD). Agarose gel electrophoresis was performed using 
1 % agarose at 125 V according to Ausubel (63).  Plasmids exhibiting the 
expected digestion pattern after enzyme digestion and gel electrophoresis were 
sequenced (University of Maryland Biotechnology Institute) to verify the 
sequence. The SDS-PAGE gels with 12 % acrylamide resolving and 5 % stacking 
and Laemmli running buffer were prepared according to standard procedures (64). 
The running protocol was following the previous published protocol by Ausubel 
at 200 V using a mini protean 3 gel system (Bio-Rad, Hercules, CA). Coomassie 
Brilliant Blue was used to stain all the protein gels. UV measurements were 
performed with a Hewlett-Packard 8453 spectrophotometer (Palo Alto, CA). 
Fluorescence measurements were made with a Hitachi F-4500 fluorescence 
spectrophotometer.  
2.2.3 Cloning, protein expression and purification.  
The Homo sapiens iodotyrosine dehalogenase protein gene (GeneBank: 
AY259176.1) was amplified by PCR using the following primers to generate a 
derivative lacking codons for amino acids 1-31 and gaining a C-terminal His6 tag, 
5’-AAGCTTAAGCTTGGATCCGCCACCATGGCTCAAGTTCAGCCC-3’ and 
5’CTCGAGCTCGAGCTAATGGTGATGGTGATGGTGTACTGTCACCATGA
TC-3’. The amplified PCR was digested with BamHI and XhoI and inserted into 
pET28-SUMO vector, in which a SUMO fusion tag was added to the N-terminal 
to improve the solubility. The resulting plasmid pET28JH1 containing the hIYD 
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gene was transformed into E. coli Rosetta 2 (DE3) (Novagen). Cells were grown 
in LB media with kanamycin and chloramphenicol at 37 ºC until an OD600 of 
0.6~0.8, expression was then induced with 0.2 mM IPTG and incubated at 18 ºC 
for 4 hours. Cells were harvested by centrifugation and were resuspended in 
buffer N (50 mM sodium phosphate (pH 8.0), 500 mM NaCl and 10 % glycerol). 
The cells were flash frozen and stored at – 80 ºC until use.  
To isolate the deiodinase, the cells were thawed and subsequently lysed by 
three passages through a French press at 1000 psi.  Cell debris was removed by 
centrifugation at 40,000×g at 4 ºC for 2 h.  The supernatant was fractionated with 
nickel ion affinity chromatography (Hispur
TM
 Ni-NTA resin, Thermo Scientific) 
that was equilibrated with buffer N. Successive washes used increasing 
concentrations of imidazole (20 mM for five column volumes (CV), 60 mM for 5 
CV, 80 mM for 2 CV and 100 mM CV) in buffer N.  The SUMO fusion of hIYD 
was finally eluted with 350 mM imidazole in buffer N and digested with Ulp1 
protease (1:200 w/w) to release hIYD from SUMO.  The resulting solution was 
concentrated to 3 ml and passed through a gel filtration column (Sephacryl S-200 
HR, GE Healthcare) equilibrated with 50 mM sodium phosphate pH 7.4, 100 mM 
NaCl, 1 mM DTT and 10 % glycerol.  Fractions containing hIYD were pooled 
and the concentration of hIYD was determined by the A280 after correcting for the 
contribution from bound FMN (A280/A450 = 1.57) (45) and an extinction 




) estimated by ExPASY ProtParam tool (65). 







(66).  The purified hIYD was concentrated to 10 mg/ml by using Amicon
®
 Ultra 
centrifugal filters prior to storage at 4 
o
C. 
2.2.4 Circular Dichroism 
CD data were collected by using a JASCO-810 at 25 °C. For far UV CD 
(190 nm-250 nm), the protein concentration is 4.1 µM in buffer (20 mM sodium 
phosphate, 0.1mM DTT, pH 7.4), cell path length is 1mm and scan speed is 50 
nm/min with response time 4 sec. The scanning of the cuvette with buffer has 
been set as baseline. After ten times scanning, the average data has been 





) (67). [E] is protein concentration, L is the path 
length, N is the number of residue. For visible CD (300 nm-500 nm), the protein 
concentration was increased to at least 60 µM in 20 mM sodium phosphate, 0.1 
mM DTT, pH 7.4 buffer with or without I-Tyr. Cuvette pathlength is 1mm and six 
times scanning for each sample at a speed of 20 nm/min and response time 16 sec. 
The baseline was set by scanning of the cuvette with buffer. The data then have 
been averaged for each sample after subtracted the baseline. After converting the 
mdeg to molar elicipity by Equation 2-2 (67), [E] is protein concentration, L is the 
pass length, and data was then graphed by Origin 7. 
Equation 2-1.            Mean residue elicipity  



















2.2.5 Deiodinase activity  





I]-I2-Tyr as reported previously (26). The assay was performed by 
adding 100 µl of hIYD (0.8 µM) to 300 µl solution 2 (1.66 mM methimidazole, 
166 mM 2-mercaptoethanol, 666 mM KCl, 333 mM potassium phosphate pH 
7.4), varied amounts of I2-Tyr (from 10 µM to 100 µM), water and 100 µl [
125
I]-
diiodotyrosine (I2-Tyr) to make the total volume 900 µl. Reactions were initiated 
by 100 µl of 10 % dithionite in 5 % sodium bicarbonate. Samples were incubated 
at 20 °C for 10 min and quenched by addition of 100 µl of 0.1 % I2-Tyr in 0.1 M 
NaOH. Aliquots of 250 µl (S) were immediately added to 4.75 ml 10 % acetic 
acid to determine the total radioactivity for each assay. The remaining 850 µl was 
then loaded onto a cation exchange column (3.5 ml, AG50W-X8 resin), washed 
with 4.15 ml 10 % acetic acid and the eluent was labeled as A. The column was 
then washed with 5 ml of 10 % acetic acid and collected as B. Radioactive I
- 
release was quantified using a Packard 1600 TR liquid scintillation analyzer after 
adding 25 ml scintillation fluid to each S, A and B,. 
Using Equation 2-3 to calculate the percent of iodide released (F) from 
each assay, the rate of iodide release (µM/h) was then calculated using Equation 
2-4. F0 is the background radioactivity obtained without adding protein. [S] is the 
substrate concentration in each sample. x is the reaction time. The product 
formation could be calculated by using Equation 2-5. Assays were performed in 
triplicate. The data set that not shown substrate inhibition were fit to Michaelis–
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Menton kinetics using Origin 7.0. The kcat value was calculated based on the 
protein concentration.  
Equation 2-3.                            




× [𝑆](𝜇𝑀) × 2  
 
Equation 2-5.                           
2.2.6 Fluorescence titration for measuring binding affinity  
Fluorescence quenching of the enzyme bound FMN (λex = 450 nm and λem 
=527 nm) was measured to determine ligand binding as described previously (68). 
Briefly, hIYD was titrated with the Tyr derivatives (I-Tyr, Br-Tyr, Cl-Tyr, and F-
Tyr) over a range of concentrations centered at that necessary for a 50 % 
quenching of the emission signal. Fluorescence intensities were normalized by 
dividing the initial fluorescence (F0) (obtained without adding substrate) and 
plotted against the ligand concentration using Origin 7. Dissociation constants 
(KD) were obtained from the nonlinear fitting to the Equation 2-6 (51).  
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2.2.7 pH dependence assay  
To assess the role of acid/base chemistry in the hIYD enzymatic reaction, 
apparent steady-state kinetics constants were determined using the standard 
deiodinase assay at pH 6.0 – 7.5 (100 mM posassium phosphate (Kpi)) and pH 
7.5 – 8.5 (100 mM Tris-HCl). All the reactions were performed under the same 
enzyme concentration ([E] = 0.08 μM). The Vmax and Vmax/KM for each pH were 
obtained as the average of the three times repeat. The logVmax and logVmax/KM 
were plotted against pH. The pH-rate profiles were fitted to Equation 2-7 (69).  
Equation 2-7.        log(y) = log(𝑦)𝑚𝑎𝑥 − log (1 + 10
𝑝𝐻−𝑝𝐾𝑎)                          
Equation 2-8.        log(y) = log(𝑦)𝑚𝑎𝑥 − log (1 + 10
𝑝𝐾𝑎−𝑝𝐻)     
The KD vs pH was measured at pH 6.0 – 8.0 (100 mM Kpi) and pH 8.0 – 
9.0 (100 mM Tris-HCl) by fluorescence titration assay as described above. The 
KD values were obtained from the average of three independent repetitions at each 
pH. The logKD was plotted against pH, and fitted to Equation 2-7 and Equation 2-
8 (69). 
 2.3 Results and Discussion 
2.3.1 Expression and Purification  
Removal of the transmembrane domain from mIYD generates a soluble, 
stable and active derivative of the deiodinase (54, 60). An equivalent truncation 
was performed on hIYD. The gene encoding hIYD but lacking the first (1-31) 
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amino acids (Figure 2-2) was inserted into the pET28-SUMO vector and 
expressed in E. coli.   
 
 
Figure 2-2. hIYD consists of three domains. A transmembrane domain [1] 
(residues 1-23), an intermediate domain [2] (residues mIYD (24-82), hIYD (24-
86)), and catalytic domain [3] (residues mIYD (82-285), hIYD (86-289)). 
 
The soluble fraction of the fusion protein (~ 50 %) was isolated by nickel-
based affinity chromatography. The SUMO tag was then removed by the protease 
Ulp1 and hIYD was isolated by size exclusion chromatography in a yield of 
~10~20 mg /1 L culture.  Native protein assembles as a homodimer and was 
isolated with the expected FMN to monomer ratio of 1.9 ~ 2.1 as determined by 
A280 and A450. The purity of hIYD approached 97 % as estimated by SDS-PAGE, 
Coomassie staining and analysis by ImageQuant TL. The desired protein migrates 
similar to the 30-kDa marker as expected for a monomer of 30.5 kDa as 




Figure 2-3. SDS-PAGE characterization of expression and purification of hIYD 
from E. coli. M illustrates the molecular weight markers. Lanes 1 refers to the 
soluble fraction of the whole-cell extracts of E. coli cultures. Lane 2 shows 
protein after purification by HisTrap column. Lane 3 shows protein after Ulp1 
digestion to remove the Sumo fusion. Lane 4 refers to pure hIYD after size-
exclusion chromatography. 
 
2.3.2 Circular dichroism spectroscopy analysis 
CD measures the difference between the absorbance of left and right 
circularly polarized light caused by the asymmetry of the solute. It has a wide 
range of applications, such as determining whether a protein is folded and 
whether protein-ligand interactions alter the conformation of the protein. 
Information can also be learned on the environments of protein’s cofactor (67). 
The difference between far-UV CD of hIYD and hIYD in the presence of I-Tyr 
illustrates the change of secondary structure caused by I-Tyr binding (Figure 2-4). 
The CD are consistent with the prior observations made from substrate-bound 
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crystal structure of mIYD (44). Substrate I-Tyr induces the formation of 
additional α-helix and β-sheet, which represent the lid of the active site.  
 
Figure 2-4. Far-UV CD spectra of hIYD. In the presence of I-Tyr (black line); 
without I-Tyr (red line), in 20 mM sodium phosphate, 0.1mM DTT, pH 7.4.  
 
Figure 2-5. Visible CD spectra of hIYD. hIYD with I-Tyr is shown in red line; 
hIYD is shown in black line. Buffer - 20 mM sodium phosphate, 0.1mM DTT, pH 
7.4. 
 
Distinct change in the visible range CD spectra was observed when I-Tyr 
was added to hIYD (Figure 2-5). The development of a negative CD signal 
around 350 nm and a weak positive CD signal in the longer wavelength range 
reveal the change of coordination of FMN upon substrate binding. These data are 
consistent with observations made from mIYD crystal structure. Upon I-Tyr 
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binding, the I-Tyr stacks on the top of FMN ring and its zwitterion region forms 
H-bonds to N3 and O4 of FMN.  
2.3.3 Deiodination activity 
The standard [
125
I]-iodide release assay was used for characterization of 
hIYD expressed in E. coli. A KM of 31 ± 6 μM and a kcat of 12.5 ± 1 min
-1
 were 










lacking its N-terminal transmembrane region (54).  
Table 2-1. Catalytic properties of iodotyrosine deiodinase homologs. 
 










 29 ± 7 8 ± 1 0.28 ± 0.07 
Sea anemone 
a
 105 ± 26 32 ± 4 0.30 ± 0.08 
Human 31 ± 6 12.5 ± 1 0.40 ± 0.05 
Zebrafish 
a
 8 ± 1 4.1 ± 0.2 0.51 ± 0.07 
Bacteria 
a
 6.6 ± 0.9 5.4 ± 0.3 0.8 ± 0.1 
Mouse 
b
 5.8 ± 0.6 6 ± 2 0.95 ± 0.33 
Lancelet 
a
 6 ± 3 7 ± 1 1.2 ± 0.6 
Daphnia 
a
 7 ± 1 17.5 ± 0.8 2.5 ± 0.4 
a,b
 parameters were reported previously (45, 54).  
 
According to the analysis on all the current available IYD homologs, all 
the key residues involved in the active site and FMN binding site are well 
conserved (Figure 1-6) (45). The steady state kinetics parameters presented in this 
study indicates that IYD from human follow the trend of the catalytic rate of the 











and KM values ranged from 6 μM to 105 μM for substrate I2-Tyr 
(Table 2-1). Among all the homologs, the kinetic parameters of hIYD are most 
close to the parameters of Honeybee.  
2.3.4 Affinity of hIYD for 3-Halotyrosines 
Binding of the various halogen-substituted tyrosines (F-Tyr, Cl-Tyr, Br-
Tyr, and I-Tyr) to IYD was monitored by the decrease in fluorescence of the 
active site FMN upon association with these ligands (See Appendices B). As 
summarized in Table 2-2, I-Tyr also binds very tightly to hIYD as well as to 
mIYD with KD values below 1 μM. The KD of hIYD to I2-Tyr is 10-fold higher 
than I-Tyr. Similar trend was found in mIYD, where the KD to I2-Tyr is 6-fold 
higher than I-Tyr (60). hIYD also associates strongly with Br-Tyr and Cl-Tyr  
 














1.5 ± 0.15 0.49 ± 0.06 6.4 
I-Tyr 0.15 ± 0.04 0.090 ± 0.04 8.53 
Cl-Tyr 0.14 ± 0.02 0.11 ± 0.03 8.35 
Br-Tyr 0.10 ± 0.01 0.15 ± 0.02 8.48 


















Values determined previously (60). 
b
 
From the literature(61) .  
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which all share KD values close to 120 nM. Only F-Tyr has a noticeably weaker 
affinity for hIYD.  Still, many orders of magnitude separate the KD values for all 
of the halotyrosines versus that for the parent tyrosine.  
The halotyrosines with similar pKa display similar binding affinity to 
hIYD (within an order of magnitude). Tyr, whose pKa is approximately 2 unite 
higher, exhibits a 1000-fold decrease in binding affinity with hIYD. These results 




Figure 2-6. The pH dependence of substrate binding to hIYD. The affinity of I2-
Tyr for hIYD (KD) is reported as the average of three independent measurements 
in the presence of potassium phosphate (■) and Tris-HCl (○) at the indicated pH 
values. Error represents the standard deviation from three measurements. Data 
were fit by non-linear least-squares regression to Equation 2-7 and Equation 2-8. 
 
2.3.5 pH dependence of I2-Tyr’s binding with hIYD   
The influence of pH on substrate binding affinity was determined 
independently by measuring the KD of I2-Tyr (Fig. 2-5) over the pH range 6-9 to 
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test if the phenolate form of substrate is the prefer form for binding. Tightest 
binding was measured near a neutral pH of 7.5.  The affinity of I2-Tyr increases as 
pH was increased from 6.0 to 7.5 as measured by the decrease in the dissociation 
constant KD (Figure 2-6). Binding affinity of I2-Tyr weakens as pH increased 
above 7.5. The importance of two ionizable groups with pKa values of 6.6 ± 0.2 
and 8.7 ± 0.3 was suggested as estimated from non-linear least-squares fitting of 
the logKD and pH to Equation 2-7 and 2-8. Deprotonating an acidic group with 
pKa ~ 6.6 and protonating a basic group with pKa ~ 8.7 enhance the binding 
affinity. The pKa of the phenolic group of I2-Tyr has been reported as 6.4  (70) 
and is similar to the value measured from the pH dependence of binding to IYD. 
Therefore, the phenolic group of I2-Tyr may represent the candidate of acidic 
group with pKa values of 6.6 as estimated from pH dependent assay. The pH 
dependent results are consistent with the previous suggestion that the phenolate 
form of the halotyrosines is the preferential binding form of IYD. Tyr has a high 
phenolic pKa of 9.1 (71) and was unable to be deprotonated at pH 7.4, resulting in 
a 1000-fold poorer binding affinity than I2-Tyr.  
The structure of mIYD•I-Tyr indicates that the phenolate of substrate 
could have polar contacts with the amide backbone of Ala126 and the 2’-hydroxy 
group of FMN. These interactions may play an important role in stabilizing the 
phenolate form of substrate and facilitate the deiodination. Similar interactions 
between substrate and the 2’-hydroxyl group of FMN has been reported in many 
acyl CoA dehydrogenases, and were found critical for stabilizing the developing 
charge (enolate form) of substrate (72, 73). BluB, the most closely structure 
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homologs of IYD in the nitro-reductase family, was found to form an equivalent 
hydrogen bond between the 2’-hydroxyl of its FMN and its substrate-molecular 
oxygen (47). The IYD may function in a similar way as acyl CoA dehydrogenase 
and BluB by generating non-aromatic keto form of the I2-Tyr as an electrophilic 
intermediate to accept reducing equivalents. A non-aromatic pyridine analogue 
used as the mimic of the intermediate keto was reported with high binding affinity 
with IYD previously, supporting the current catalytic mechanism (Figure 2-7) that 




Figure 2-7. Stepwise one-electron transfer catalytic mechanism of IYD. 
 
The proposed basic group that affects binding is likely the α-ammonium 
group of I2-Tyr (pKa of 7.8 )(71).  According to the crystal structure of mIYD·I2-
Tyr, the α-ammonium group of I2-Tyr form polar contacts to residues Glu157 and 
O4 of FMN, and may important for the close of the active site lid and properly 
position of substrate between IYD and FMN. Another candidate for this basic 
group might be the N3-H of FMN. Although its pKa in free solution is reported to 





Figure 2-8. The pH dependence for deiodination of I2-Tyr by hIYD. The pH 
profile of (A) logV and (B) logV/K were fit by non-linear least-squares regression 
using Eqation 2-7. Each data represents an average of three independent 
measurements in the presence of potassium phosphate (■) and Tris-HCl (○) at the 
indicated pH values. 
 
2.3.6 pH dependence of I2-Tyr deiodination by hIYD 
Kinetic analysis of I2-Tyr deiodination by hIYD was repeated over a pH 
range of 6.0 - 8.5 (Fig. 2-8) to investigate the ionizable residues that is critical for 
catalysis.  The maximum activity was measured at the lowest pH 6.0.  The pH rate 
profiles of both logV and logV/K illustrate a basic limb with a slope of -1. Their 
respective pKa values of 7.5 ± 0.2 and 7.6 ± 0.2 as determined by Equation 2-7 are 
within experimental error and are consistent with the protonation of a functional 
group with a pKa of 7.5 – 7.6. The similarity in the pH dependence of V and V/K 
indicates that the catalytic parameter kcat dominates the profiles. Few candidates 
are apparent for this ionizable group other than the α-ammonium group of I2-Tyr. 
Its interaction with the O4 of FMN may help orient substrates with regard to the 
isoalloxazine system and modulate the oxidation-reduction properties of this 




In this chapter, an efficient expression and purification of hIYD was 
developed. This system will accelerate the research progress on hIYD due to its 
simplicity and capability of providing large quantities of protein for further 
research. The kinetic parameters of hIYD are similar to that for other IYD 
homologues. The investigation of binding affinity of hIYD with halotyrosine 
derivatives also showed a similar trend as mIYD in regarding binding affects and 
pKa of the phenolic group. Both suggest that the phenolate form of the 
halotyrosines binds preferential to IYD. The pH dependent of bind leads more 
evidence to this hypothesis. Deprotonating the phenolic group of I2-Tyr was found 
critical for its binding. The pheolate form of substrate was thought to be stabilized 
by the interactions from the 2’-hydroxyl of its FMN. Protonating of another 
ionizable group with a pKa around 7.6 was found to be important for catalytic. 
The most likely candidate for this ionizable group was the α-ammonium group of 
I2-Tyr, which may participate in position substrates with regard to FMN as well as 





Chapter 3: The influence of substrate binding on redox property 
and structure 
3.1 Introduction 
The redox chemistry of flavin depends on its coordination with its protein 
environment. Important interactions to FMN redox state include hydrogen-
bonding interactions at its N1, O2, N3, O4 and N5, electrostatic interactions, the 
aromatic stacking of the isoalloxazine ring, solvent accessibility and bend of the 
isoalloxazine ring (40, 75-78). As observed in structure of mIYD•I-Tyr, substrate 
binding induces closure of the active site lid and dramatically changes on the 
coordination of FMN by addition of H-bonding to N3, O4 and N5 of FMN and 
aromatic stacking (Figure 3-1) (44). Thus, substrate binding is expected to change 
the redox properties of FMN in IYD and facilitate the deiodination process. 
 
 




Redox potential shows the tendency of a chemical species to acquire 
electrons. The more negative the potential, the less the species’ affinity for 
electrons and tendency to be oxidized (79). For free FMN in solution, the 
midpoint redox potential (Em) for the oxidized/semiquinone couple and 
semiquinone/reduced couple is -0.314 V and -0.124 V, respectively, at pH 7 (80). 
Due to the different of protein’s ability to stabilize the semiquinone state of FMN, 
the redox potential of FMN in bound protein vary widely (81). The only report on 
the redox potential of IYD was published in 1979 using IYD purified from bovine 
thyroid microsomes (27). Titration of this IYD with dithionite suggested the 
presence of neutral semiquinone species (absorbance at 585 nm). The midpoint 
potential of this IYD was reported as -0.190 V and -0.412 V for the 
oxidized/semiquinone couple and the semiquinone/reduced couple, respectively 
(27). However, the potentiometric method used was unable to differentiate the 
kinetically and thermodynamically stable semiquinone. A kinetically semiquinone 
will dissipate quickly. In contrast, a thermodynamically stable semiquinone will 
persist in the presence of an electron shuttle, such as the redox dye methyl 
viologen.  
A method using xanthine/xanthine oxidase as reducing system is able to 
determine the redox potential based on UV/VIS spectra of the thermodynamically 
stabilized redox state of flavin (32). A low concentration of xanthine oxidase is 
used to realize the slow reduction to ensure that the redox equilibrium is 
established between the flavin and  a reference dye (32, 79, 82). The redox 
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potential of flavin can be obtained after calculating its difference with the 
reference dye of known redox potential by using Nernst equation (32). Reference 
dyes were selected so that they would be reduced concourse with hIYD, which 
requires redox potentials within 30 mV of each other. Moreover, the indicator and 
protein should have distinct absorbance during reduction process to enable the 
calculation of their concentrations independently.  
In this chapter, the crystal structure of hIYD and hIYD•I-Tyr is presented 
to illustrate structural influence of FMN coordination caused by I-Tyr binding in 
hIYD. To understand the contribution of structural change on the redox of FMN, 
the redox property of hIYD in the presence or absence of F-Tyr was investigated 
by xanthine/xanthine oxidase method. The F-Tyr analog exhibits tight binding to 
IYD, however, it does not turn over with IYD (68). Replacing the native substrate 
I-Tyr with F-Tyr is intended to focus the investigation on substrate binding 
induced change of the redox property of FMN instead of catalytic turnover.  
3.2 Materials and Methods 
3.2.1 General methods and materials 
Protein expression and purification follow the protocols described in 
Chapter 2. UV/VIS spectra were obtained with a Hewlett-packard 8453 
spectrophotometer (Palo Alto, CA). Biochemical reagents including xanthine 
oxidase were purchased from Sigma Chemicals and used without further 
purification unless specified. F-Tyr and Nile Blue were obtained from Astatech, 
Inc. and Santa Cruz Biotechology, Inc., respectively. 
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3.2.2 Protein crystallization, structure determination and refinement. 
Crystallization trials utilized a Phoenix crystallization robot and sparse 
matrix screening WizardTM I, II, III and IV (Emerald Biosciences), PEGSuiteTM 
and CryoSuiteTM (Qiagen) and IndexTM (Hampton Research). After 
optimization, hIYD crystals grew in approximately 2 days at 20 ºC by the hanging 
drop diffusion method with a ratio of 1 μl hIYD (12 mg/ml, 50 mM sodium 
phosphate pH 7.4, 100 mM NaCl, 1 mM DTT, 10 % glycerol) and 1 μl precipitant 
(0.05 M ammonium sulfate, 50 mM BisTris (pH 6.5), and 25 % pentaerythritol 
ethoxylate.  Crystals were cryoprotected in the precipitant supplemented with 15 
% glycerol and 1 mM FMN for prior to data collection. To generate co-crystals, 
hIYD was treated with 1.5 mM I-Tyr overnight at 4 ºC and then subject to the 
same hanging drop procedure using a well solution of 0.15 M sodium acetate, 85 
mM Tris-HCl pH 8.5, 25.5 % w/v polyethylene glycol 4,000 and 15 % glycerol at 
20 ºC.  Co-crystals of hIYD·I-Tyr formed within 24 hours and were flash frozen 
in liquid nitrogen.   
X-ray diffraction data were collected at beamline 7-1 at the Stanford 
Synchrotron Radiation Laboratory.  Data were processed using the HKL2000 
package (83).  The structures of hIYD and hIYD·I-Tyr were solved by molecular 
replacement using AutoMR in PHENIX by Dr. Watchalee Chuenchor (84). Final 
refinement statistics for both structures are summarized in Table 3-1.  All images 
were prepared using Pymol (Schrödinger, LLC). Structure factors and coordinates 
have been deposited with the Protein Data Bank at PDB under accession number 
4TTB and 4TTC. 
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Table 3-1. Data collection and refinement statistics. 
 
Protein hIYD-FMN hIYD-FMN-I-Tyr 
Ligands FMN FMN and I-Tyr 
PDB code 4TTB 4TTC 
Data collection   
Space group P31 P61 
No. Molecule/ASU 2 6 
Unit cell parameters  
(Å, °) 
a = 72.89, 
b = 72.89, 
c = 95.51 
a = 104.75, 
b = 104.75, 
c = 303.34 
  = 90,  = 90,  = 120   = 90,  = 90,  = 120  
Resolution range (Å)
a
 50-2.45 (2.54-2.45)      50-2.65 (2.74-2.65) 
No. of unique reflections
a
 20957 (2074) 54565 (5465) 
No. of observed reflections 172255 522006 
Completeness
a
 100 (100) 100 (100) 
Redundancy
a





 6.1 (61) 8.8 (55.4) 
I/σI
a
 33.8 (2.9) 27.1 (4.9) 
Refinement   
Resolution used in refinement (Å) 38.09-2.45 44.86-2.65 
No. of reflections used in working set 18749 54432 
No. of reflections for Rfree calculation 1874 2708 
Rwork
 
(%),  Rfree (%) 18.17, 23.64 19.02, 22.14  
No. atoms   
     Protein 3042 (A-B)  10680 (A-F) 
     Hetero atoms 62 (FMN) 186/84 (FMN and I-Tyr) 
     Solvent 42 221 
Mean B-factor (Å
2
)   
     Protein 86.2 52.3 
     FMN 85.8 37.8 
     I-Tyr None 40.1 
     Solvent 62.7 41.8 
RMSD from ideality   
     Bond lengths (Å) 0.008 0.008 
     Bond angles (deg.) 1.142 1.059 
Ramachandran analysis   
     Favored (%) 98.4 97.4 
     Allowed (%) 100 100 







 Numbers in parentheses are outer shell parameters. 
 
3.2.3 Anaerobic Titration  
All titrations were performed at 25 ºC using xanthine/xanthine oxidase as 
the reducing system (32, 82).  Individual samples within sealable quartz cuvettes 
contained 10-15 μM hIYD, 900 μM xanthine, 2 μM methyl viologen, 200 mM 
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potassium chloride and 100 mM potassium phosphate pH 7.4. Molecular oxygen 
was removed from these solutions by continuously flushing with argon for at least 
20 min prior to addition of hIYD.  Reaction was initiated by addition of 40 μg/ml 
xanthine oxidase.  Spectra changes were monitored every 2 min.  Titrations were 
also repeated in the presence of F-Tyr (0.6 mM) to investigate the effect of ligand 
binding on the oxidation-reduction properties of the enzyme-bound FMN.  
Redox potential measurement is based on the method described by Massey 
(32, 82). The following reference dyes were used as indicator: anthraquinone-2,6-
disulfonate (AQDS, Em= -188 mV), nile blue (Em= -116 mV), or safranin O (Em= 
-280 mV) (85). The UV/VIS spectral changes were recorded every 2 mins for 
over 2 hours. The concentration of species are determined at a wavelength at 
which the other redox partner has an isobestic point between the oxidized and 
reduced forms or has no absorbance at all. The potential at 50 % reduction of 
flavoenzyme can be calculated by the Nernst equation (82): 
Equation 3-1.      Eh(dye) = Em(dye) + 2.303(RT/ndyeF)log(dyeox/dyered) 
Equation 3-2.           Eh(E) = Em(E) + 2.303(RT/nEF)log(Eox/Ered)    
At equilibrium, Eh(dye) = Eh(E) 
Equation 3-3.  
Em(E) + 2.303(RT/nEF)log(Eox/Ered)= Em(dye) + 2.303(RT/ndyeF)log(dyeox/dyered) 
Equation 3-4. 








). At 25℃, ndyeF/2.303RT= ndye/59 mV. After 
calculate the concentration of each species, plot the log(Eox/Ered) VS 
log(dyeox/dyered) and linear analysis the data by Origin 7. The Y-intercept value 
was used to calculate the midpoint redox potential of the enzyme. To make the 
analysis reliable, the first 10 % and last 10 % reaction data was not be included. 
All mid-point potentials are reported versus the standard hydrogen electrode and 
represent the average of three independent determinations. 
3.3 Results and Discussion 
3.3.1 Structural determination of hIYD 
The structure of hIYD and hIYD·I-Tyr were solved from different crystal 
forms by molecular replacement with previously described for mIYD and 
mIYD·I-Tyr (44, 46). hIYD crystallized with one dimer per asymmetric unit. The 
hIYD·I-Tyr complex crystallized with three dimers per asymmetric unit. All the 
parameters were summmerized in Table 3-1. Similar to the mouse IYD structure, 
electron density for the first 39 residues (32-70) representing part of the 
intermediate domain of hIYD was not observed in either hIYD diffraction 
patterns. Truncation of this flexible region may help improve the quality of the 
crystal. However, truncation of the 32-70 residues resulted in 90 % of hIYD 
insoluble when expressed in E.coli and no further deletions were attempted. This 
intermediate domain likely stabilizes the homodimeric structure or at least aids in 





Figure 3-2. Comparison between structures of hIYD and hIYD•I-Tyr. The 
structure of hIYD•I-Tyr (deep blue and deep purple to indicate the two 
monomers) is overlaid with the structure of hIYD (light blue and light pink to 
indicate the two monomers). The active site lid composed of a loop (residues 199-
211) and a helix-turn (residues 161-178) are only detected in the hIYD·I-Tyr co-
crystal. 
 
hIYD belongs to the nitroreductase superfamily and its structure shares 
some common feature with all the other members of this family. The two identical 
subunits of hIYD consist of a typical α-β fold swap (Figure 3-2). The FMN is 
bound non-covalently to the hIYD at the interface of two helices formed by the 
two monomers. The FMN is flat (bend angle < 2º) and interacts through hydrogen 
bonds and hydrophobic region to both subunits. The phosphate group of FMN is 
coordinated by Arg-100, Arg-101 and Arg-279, all from the same subunit (Figure 
3-4). The hydroxyl groups of Ser-102 and Ser-128 from different subunits form 
hydrogen bonds to the ribose group of FMN. Arg 104 maintains hydrogen bond 
with O
2
 of FMN. The structures of hIYD and its co-crystal with I-Tyr are nearly 
superimposable (RMSD of 0.226 Å for a 398 atom comparison) (Fig 3-2). 
However, in the absence of substrate I-Tyr, the electron density of residues of 
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160-181 and 199-212 was not detected in the structure of hIYD. The presence of 
bound I-Tyr increases the order of this region, forming as a lid (a helix and loop) 
in the structure of hIYD·I-Tyr, covering the I-Tyr and FMN active site and 
sequestering it from solvent out (Fig 3-3).  
 
 
Figure 3-3. The active site lid shields the substrate and FMN from solvent. A) The 
two identical polypeptides within the hIYD•I-Tyr structure are indicated by 
shades of grey. FMN and I-Tyr reside in the active site and are depicted in color. 
Residues 161-178 of one polypeptide are not shown in order to reveal the position 
of FMN and I-Tyr. B) The surface formed by residues 161-178 of the same 
polypeptide is highlighted in blue to illustrate their ability to cover the active site. 
 
The FMN forms additional critical interactions to the substrate I-Tyr and 
active site residues in hIYD as indicated in Figure 3-4. The zwitterionic region of 
I-Tyr forms H-bonds to the N3 and O4 of the FMN. Thr-239 additionally moves 
toward to the FMN. The distance between the OH side chain of Thr239 and the 
N5 of FMN changes from 4.8 Å to 3.1Å and allows the formation of a hydrogen 
bond. Further contact is made by the aromatic ring of I-Tyr stacking above the 
FMN with its closest approach between the FMN N10 and the phenolic oxygen of 
I-Tyr.  The C-I bond of I-Tyr orients directly over the C4a-N5 bond of FMN that 
is crucial during redox cycling of many flavoproteins (81, 86). These substantial 
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changes in the environment around the isoalloxazine ring of FMN suggested that 




Figure 3-4. Details of the active site interactions around FMN. The surrounding 
residues from hIYD•I-Tyr (deep blue and deep purple to indicate from two 
monomers) are overlaid with the residues from hIYD (light blue and light pink to 
indicate from two monomers). Substrate I-Tyr is illustrated in green. For the 
structure lacking substrate, the FMN is depicted in grey. For hIYD·I-Tyr, the 
FMN is depicted in yellow. 
 
hIYD shares 87 % sequence identity with mIYD. The structure of hIYD•I-
Tyr and mIYD•I-Tyr are nearly superimposable (Figure 3-5), indicating that the 
structures of the flavin binding site and the active site in IYD are conserved. In 
both hIYD•I-Tyr and mIYD•I-Tyr, substrate binding induces the same formation 
of an active site lids consisting of a loop and helix. The four known human 
mutations that compromise IYD activity and result in thyroid disease as predicted 
earlier from the mIYD model map to the hIYD structure (15, 19, 44). One of the 
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most severe mutations is R101W that effects a key stabilization interaction with 
the protein and the phosphate group of FMN (Figure 3-4).  
 
 
Figure 3-5. Comparison between structures of human and mouse IYD with bound 
I-Tyr. Individual polypeptides of hIYD•I-Tyr (purple and blue, Protein Data Bank 
code 4TTC) are overlaid with the corresponding polypeptide structure from 
mIYD•I-Tyr (gray, Protein Data Bank code 3GFD). 
 
3.3.2 The effect of substrate binding on the reduction of hIYD.  
UV visible spectroscopy was used to characterize the bound FMN in 
hIYD. The absorbance of oxidized hIYD has a maximum at 446 nm and a 
shoulder around 460 nm. Anaerobic reduction of hIYD by the xanthine and 
xanthine oxidase system decreases the absorbance at 446 nm rapidly and share an 
isosbestic point at 325 nm (Figure 3-6 A). The oxidized FMN is reduced to the 
two-electron reduced FMN without observation of accumulation of one electron 
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reduced semiquinone. Only oxidized FMN and fully reduced FMN are 
thermodynamically stable during the course of the titration of hIYD demonstrated 





Figure 3-6. Aanaerobic reduction of hIYD by xanthine and xanthine oxidase as 
observed by UV/VIS. A. Arrows at 446 nm indicate direction of absorption 
change during the reduction process in the absence of F-Tyr; B. Arrows at 590 nm 
indicate that absorptions were first increase and then followed with decrease in 




In contrast, in the presence of F-Tyr, spectral changes of hIYD occurring 
during an equivalent titration indicates the accumulation of neutral semiquinone 
(Figure 3-6 B) with a peak at 590 nm and a shoulder around 610 nm (32). 
Accumulation of the neutral semiquinone was observed indicating that the 
binding of F-Tyr caused a change of the FMN environment significantly enough 
to stabilize the neutral semiquinone form of FMN (Figure 3-3). Prolonged 
reduction results in the gradual disappearance of this long wavelength peak and 
the appearance of the spectrum of fully reduced FMN. As a result, in the presence 
of F-Tyr, reduction of hIYD leads to two stepwise single electron transfer phases. 
The first phase is the reduction of oxidized FMN to the neutral semiquinone. The 
second phase of reduction converts the neutral semiquinone to the fully reduced 
flavin. Observation of the semiquinone suggests that there is a large separation 
between the midpoint potentials of the two reduction steps.   
 
3.3.3 The effect of substrate on the redox potential of FMN in hIYD  
Redox titration of hIYD was repeated in the presence of suitable redox 
indicators to determine the redox potential of the FMN cofactor in hIYD. Initial 
test indicates that the redox potential of anthraquinone-2, 6-disulfonate (AQDS) is 
comparable to redox potential of FMNox/hq and can be reduced simultaneously 
with hIYD. This dye was used as the reference dye to measure the midpoint 
potential of the two electrons couple for FMNox/sq. The plot of log (FMNox/hq) 
versus log (AQDSox/red) gives a slope of 0.96, indicative of two-electron processes 
for both AQDS and hIYD. A value of - 200 mV for the midpoint redox potential 
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of FMNox/hq (Figure 3-7) was calculated by Equation 3-4. The Em of hIYD in the 




Figure 3-7. Selected spectra for the reduction of hIYD flavin in the presence of 
AQDS by the xanthine/xanthine oxidase. The reaction was monitored over 120 
min. The arrows indicate the direction of the changes in absorbance. Insert: plot 
of log(FMNox/FMNhq) vs log(AQDSox/AQDSred). The concentrations of 
oxidized and reduced AQDS were calculated by the absorbance at 325 nm (the 
isosbestic point of hIYD). The amount of FMN and FMNH2 was quantified based 
on the absorbance at 355 nm (the isosbestic point of AQDS).  
 
As described above, the substrate analogue F-Tyr converts the reduction 
of hIYD to a stepwise single-electron transfer process. For the reduction of 
FMNox to FMNsq, nile blue (NB) was observed to be reduced at the same time as 
the FMNox/sq couple in hIYD. As shown in Figure 3-8, a slope of 1.9 was obtained 
after plotting the log (FMNox/sq) versus log (NBox/red) indicative of a two-electron 
process for NBox to NBred and an one-electron process for FMNox to FMNsq. The 





Figure 3-8. Selected spectra showing the reduction of oxidized FMN to neural 
semiquinone FMN in hIYD in the presence of substrate analogue F-Tyr and NB 
by xanthine/xanthine oxidase. Insert: plot of log(FMNox/FMNsq) vs 
log(NBox/NBred). Concentrations of oxidized forms of dye and flavin were 
calculated by the absorbance at 450 nm and 650 nm separately.  
 
For FMNsq to FMNhq, Safranin O (SFO) was selected since both FMNsq 
and dye were reduced concurrently. The plot of log (FMNsq/hq) vs log (SFOox/red) 
should give a slope of 2 since SFO is a two-electron acceptor and FMNsq to 
FMNhq is a one-electron process. A slope of 1.2 was observed instead (Figure 3-
9). A kinetic barrier for the reduction process may lead to this error as reported in 
other enzyme (88, 89). A value of - 310 mV for the midpoint redox potential of 





Figure 3-9. Reduction of FMNsq to FMNhq in hIYD in the presence F-Tyr and 
SFO by xanthine/xanthine oxidase. The arrows indicate the direction of the 
changes in absorbance. Insert: plot of log(FMNsq/FMNhq) vs 
log(SFOox/SFOred). Concentrations of oxidized forms of dye and FMNsq were 
calculated by the absorbance at 520 nm and 610 nm separately. 
 




is 154 mV. 
We could use equation 3-5 and 3-6 to estimate the extent to which semiquinone 
accumulated before its further reduction (85, 90). K is the semiquinone formation 
constant, I is the concentration of semiquinone, and S is the total enzyme 
concentration. According to the calculation, this accumulation corresponds to ≈ 
99 % FMNsq formation before further reduced to FMNhq. 







Equation 3-6.         Em(FMNox/sq)
 
 –Em(FMNsq/hq)= 2.303 (RT/F) log K 
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3.3.4 A comparison of the redox properties of hIYD with other flavoprotein 
The ability of substrate to promote the stepwise single electron transfer 
process is consistent with the previous conclusion that BluB and IYD represents a 
new subfamily of nitro-FMN reductase since BluB are oxygen-insensitive 
reductase involving a single-electron transfer mechanisms (9, 47). In contrast, all 
the other members of the nitro-FMN promote a two-electron transfer mechanism. 
This difference may be caused by the different FMN coordination, especially the 
difference of N5 H-bonding of FMN as descried in chapter 1. 
Though unusual in nitro-FMN reductase family, stabilization of the blue 
neutral form of the flavin semiquinone radical is very common in the flavodoxin 
family (39). Similar to hIYD, most flavodoxin also establish a very low one-
electron reduction potential for the semiquinone-hydroquinone couple and a large 
separation (>100 mV) between its Eox/sq and Esq/hq. For example, the midpoint 
potential for the bounded FMN Eox/sq and Esq/hq in the clostridium beijerinckii 
flavodoxin are – 92 mV and – 399 mV at pH 7, respectively (77). For the 
Megasphaera elsdenii flavodoxin, the midpoint potential for the bounded FMN 
Eox/sq and Esq/hq are – 115 mV and – 372 mV at pH 7, respectively (91). For the 
Escherichia coli flavodoxin, the midpoint potential for the bounded FMN Eox/sq 
and Esq/hq are – 244 mV and – 455 mV at pH 7, respectively (39). Large 
separation (>100 mV) of its two potentials are result from the stabilization and 
accumulation of the blue semiquinone. A very low redox potential for the 
FMNsq/hq indicates that hydroquinone is unfavorable and does not accumulate. 
Based on the available structure and mutations in the flavodoxin, unfavorable 
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electrostatic and aromatic stacking interactions are considered critical for 
controlling the reduction of flavin. In hIYD, similar π-π stacking between I-Tyr 
and isoalloxazine ring of FMN are established (Figure 3-10) and may also be 
necessary for stabilization of FMNsq and destabilization of FMNhq.  
 
 
Figure 3-10. Aromatic stacking between I-Tyr and FMN observed in structure of 
hIYD•I-Tyr. I-Tyr stacks over FMN and establishes numerous polar contacts with 
FMN in the active site of hIYD. Distances in Å are included. 
 
Ligand binding induces the modulation of the redox property of flavin has 
also been reported in certain acyl CoA dehydrogenases (72, 73). In these 
flavoproteins, the electron donating property of reduced flavin was largely 
affected by the presence of an enoyl CoA product and facilitates the subsequent 
transfer of its electrons to the electron carrier.  
3.4 Conclusion 
Solving the crystal structure of hIYD provided the structural base for 
molecular analysis on hIYD related disease. Association of I-Tyr significantly 
changes on the coordination surrounding the isoalloxazine ring of FMN. Those 
changes are similar to those observed in mIYD•I-Tyr including aromatic stacking 
between I-Tyr and FMN, H-bonding to N5 of FMN, H-bonding interacts between 
zwitterion region of I-Tyr and the N3 and O4 of the FMN. Those coordination 
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changes on FMN induced by substrate binding were thought critical for the redox 
control of FMN. 
Redox titration analysis indicates that the substrate binding indeed 
dramatically affect the redox property of hIYD. The substrate analogue F-Tyr was 
used in place of I-Tyr in order to observe FMN reduction without catalytic 
turnover. In the absence of any active site ligand, the midpoint potential is similar 
to that of FMN in solution and only FMNox and FMNhq could be observed during 
reduction. In contrast, a neutral FMNsq became a distinct intermediate during 
reduction of FMNox upon F-Tyr binding to hIYD indicating a definitive switch to 
a stepwise one-electron reduction process. According to our current knowledge, 
this is the first report of substrate binding inducing stabilization of neutral 




Chapter 4:  The role of H-bonding to FMN N5 in hIYD for redox 
control and deiodination 
4.1 Introduction 
Electron transfer is essential for the catalytic reactions of most 
flavoproteins. Protein must tightly control the lifetimes of flavin radical 
intermediates to facilitate the electron transfer. The N5 atom of the flavin ring is 
one of the most important positions for redox control since the N5 atom can either 
be a hydrogen bond donor or acceptor based on its redox state (92). Forming or 
breaking a N5 H-bond could control of the lifetime of the semiquinone flavin. 
Moreover, the strength of hydrogen bond to N5 was also shown to have a 
significant influence on the redox states of flavoprotein (75, 78, 93, 94).  
As described in Chapter 3, substrate binding induces the stabilization of 
the neutral semiquinone form of FMN and converts the reduction of FMN from a 
single two-electron transfer process to two stepwise single electron transfer 
processes. Structural comparison of hIYD and hIYD•I-Tyr indicated that substrate 
binding induces a movement of the OH side chain of Thr239 toward the N5 atom 
of the FMN allowing the formation of H-bonding between them. As shown in 
Figure 4-1, the Thr239 is the turn between two helices of the active site lid. 
Substrate binding causes the rearrangement of the turn, the distance between the 





Figure 4-1. Substrate binding induces the movement of Thr239 toward N5 of 
FMN. For hIYD•I-Tyr (PDB ID: 4TTC), residues are in deep blue, FMN in 
yellow and I-Tyr in green. In hIYD (PDB ID: 4TTB), residues are shown in light 
blue and FMN are in gray. 
 
This N5 H-bond of FMN in hIYD is similar to the N5 H-bond of FMN in 
BluB, its closest member in the nitro-FMN reductase superfamily. In BluB, the 
N5 H-bond of FMN is also derived from an OH side chain (Ser167). Based on 
current publications on the nitro-FMN reductase family, hydrogen bonding 
between protein and the N5 of the isoalloxzine ring is very common but usually 
derives from the N-H backbone as indicated in Table 4-1. For example, the N5 
hydrogen bonds in NTR, FRase 1, FRP, NOX, NfsA and RdxAl are derived from 
the backbone N-H and all of them are oxygen-insensitive reductases that 
supporting only two electron reduction processes. However, BluB is shown 
oxygen-sensitive and able to promote one electron transfer to activate its 
substrate, molecular oxygen. This in turns implies a stepwise one electron 
reduction process. Moreover, the Ser 167 of BluB was also found critical to the 
catalytic activity, mutation of Ser 167 to Gly reduces the product formation 30-
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fold, and mutation to Cys caused complete loss of activity (47). Considering the 
importance of N5 H-bonding for stabilization of the flavin radical in other 
flavoproteins and the similarity of N5 H-bonding in IYD and BluB, we assumed 
that this N5 H-bonding in hIYD•I-Tyr may represent the primary coordination to 
stabilize of semiquinone. 
 
Table 4-1. The N5 H-bonding of FMN in nitro-FMN reductase superfamily. 
 
Protein PDB code To N5  Group ET process Reference 
hIYD 4TTC Thr239 OH side chain 1e ?  
BluB   2ISJ Ser167 OH side chain 1e (47) 
NTR 1DS7 Glu165 NH back bond 2e (95) 
FRase I 1VFR Glu165 NH back bond 2e (96) 
FRP 2BKJ Gly130 NH back bond 2e (49) 
NOX 1NOX Leu158 NH back bond 2e (48) 
NfsA 1F5V Gly130 NH back bond 2e (97) 
RdxA 3QDL Gly162 NH back bond 2e (98) 
 
To understand the significance of N5 H-bond of FMN in semiquinone 
stabilization and deiodination process of IYD, mutation of Thr239 to Ser and Ala 
is generated in this chapter. Mutant T239A removes the OH group to eliminate 
the N5 H-bond between OH of Thr239 and N5. However, N5 may still form a H-
bond with H2O in T239A if there is any water molecule close to the N5 of FMN. 
To provide more information on the interactions to the N5 of FMN in T239A 
mutants, a crystal structure of T239A•F-Tyr is also presented. The redox property 
of the both mutants in the presence and absence of ligand were also investigated 
and compared with wild type hIYD to illustrate the importance of N5 H-bond in 
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redox control in hIYD. The kinetics of deiodination was also measured in this 
chapter to understand the significance of N5 H-bond in catalytic process. 
4.2 Materials and Methods 
4.2.1 General methods 
Proteins were expressed in Rosetta2 DE3 E.coli and purified by two steps 
(Ni
2+ 
column and size exclusion column) as described in Chapter 2. Redox 
titration was performed by the xanthine/xanthine oxidase method as described in 
Chapter 3. UV measurements were obtained with a Hewlett-Packard 8543 
spectrophotometer. Fluorescence titration was used to measure the dissociation 
constant of ligands as described in Chapter 2. Kinetics parameters were 
determined by radioactive assay using [
125
I]-diiodotyrosine as substrate and 
dithionite as reducing reagent as reported previously. Assays were performed in 
triplicate. The data were averaged and fit to the Michaelis-Menten equation by 
Origin 7.0 (Northampton, MA). Errors of Km and Vmax represent the error of 
fitting.  
4.2.2 Site-directed Mutagenesis 
Site-directed mutagenesis was performed on plasmid pETSUMO-hIYD to 
generate the T239S and T239A mutants. T239S was created by using primer 5’- 
GGTGACTGTCACCACGAGTCCTCTCAACTGTGGCC-3’ and its complement 
5’-GGCCACAGTTGAGAGGACTCGTGGTGACAGTCACC-3’. T239A mutant 
was generated by using a forward primer of 5’-
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CTGGTGACTGTCACTACGGCGCCTCTCAACTGTGGCC -3’ and its 
complement 5’-GGCCACAGTTGAGAGGCGCCGTAGTGACAGTCACCAG-
3’. Mutations were confirmed by sequencing. The mutants were transformed to 
electro-competent cell Rosetta 2(DE3) E.coli for expression.  
4.2.3 Crystallization of hIYDT239A·F-Tyr 
To obtain the hIYDT239A·F-Tyr co-crystal, hIYDT239A was pre-
incubated with 3 mM F-Tyr. hIYDT239A·F-Tyr crystallized in approximately 2 
days at 20 ºC by the hanging drop diffusion method with a ratio of 0.8 µl 
hIYDT239A (11.7 mg/ml, 50 mM sodium phosphate (pH 7.4), 100 mM NaCl, 1 
mM DTT, 10 % glycerol) to 1 µl precipitant containing 0.17 M sodium acetate, 
85 mM Tris-HCl (pH 8.5), 22.5 % w/v polyethylene glycol 4,000 and 15 % 
glycerol. The crystals were flash frozen in liquid nitrogen. X-ray diffraction data 
were collected at National Synchrotron Light Source beamline X-25. All collected 
data were processed using HKL2000 package (83). Molecular replacement was 
performed by PHASER within the CCP4 program suite using a dimer of mIYD·I-
Tyr (PDB code 3GFD) with all heteroatoms removed and B-factors set to 20.0 
(square Angstroms) (44, 99). Three iterations of PHASER were performed to 
yield a model with six monomers per asymmetric unit, as predicted by Matthews 
coefficient calculations. Iterative manual model building and addition of water 
molecules, FMN, and the F-Tyr ligand were performed in COOT and refined by 
Refmac in CCP4 (100). The final refinement statistics are summarized in Table 4-
2. All structure figures were prepared with Pymol.  
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Table 4-2. Data collection and refinement statistics for hIYDT239A. 
 
Protein hIYDT239A-FMN-F-Tyr 
Ligands FMN and F-Tyr 
Data collection  
Space group P61 
No. Molecule/ASU 6 
Unit cell parameters  
(Å, °) 
a = 105.079, 
b = 105.079, 
c = 300.202 
  = 90,  = 90,  = 120  
Resolution range (Å)
a
      49.59-2.30  
No. of observed reflections 661766 
No. of unique reflections
a
 82734 (5790) 
Completeness
a
 100 (100)  
Redundancy
a





 9.3 (35.1) 
I/σI
a
 41.5 (6.5) 




Resolution used in refinement (Å) 46.52-2.30 
No. of reflections used in working set 78650 
No. of reflections for Rfree calculation 4144 
Rwork
 
(%),  Rfree (%) 18.30, 22.58  
No. atoms  
     Protein  11102 (A-F) 
     Hetero atoms 186/84 (FMN and YOF) 




     Protein 48.8 
     FMN 38.3 
     F-Tyr 37.7 
     Solvent 42.7 
RMSD from ideality  
     Bond lengths (Å) 0.012 
     Bond angles (deg.) 1.543 
Ramachandran analysis  
     Favored (%) 97.5 
     Allowed (%) 2.5 
     Outliers 0 
a




4.3 Results and Discussion 
The H-bond between N5 of FMN and Thr239 in the structure of hIYD·I-Tyr 
was assumed critical for stabilization of the semiquinone FMN. To understand the 
importance of N5 H-bond on the redox control of FMN in hIYD, mutants T239S 
and T239A were generated individually by standard site-directed mutagenesis. 
The mutants alter or eliminate the hydrogen bond donor to N5 atom of FMN. 
Both mutants were expressed in E.coli in a soluble form. After purification, >95 
% pure proteins were obtained. The binding affinities of the mutants with ligands 
(I-Tyr and F-Tyr) were determined before the redox analysis.  
 
Table 4-3. Characterization of mutants T239S and T239A. 
 
    hIYD hIYDT239S hIYDT239A 
KD  I-Tyr µM 0.15 ± 0.04 0.37 ± 0.07 0.20 ± 0.05 
 F-Tyr µM 1.3 ± 0.3 3.3 ± 0.5 1.5 ± 0.2 
Kinetics 
 
 KM µM 31 ± 6 17 ± 3.9 55 ± 10 
 kcat min
-1





 0.4 ± 0.1 0.7 ± 0.17 0.06 ± 0.01 
Redox 
titration 
- F-Tyr Em (FMNox/hq) mV -200 ± 4 -206 ± 3 -215 ± 4 
+ F-Tyr semiquinone  99 % 55 % N/D 
Em(FMNox/sq) mV -156 ± 2.3 ~ -234  Em 
(FMNox/hq) 
-272 ± 4 
Em(FMNsq/hq) mV -310 ± 3.5 ̶ 
 
4.3.1 Influence of N5 H-bond on ligand binding property 
The KD values of T239S and T239A for I-Tyr and F-Tyr were measured 
by fluorescence titration (Appendices D) and summarized in Table 4-3. The 
binding affinity of the mutants to I-Tyr and F-Tyr are very similar to wild type 
hIYD. Both mutants exhibit tight binding to native substrate I-Tyr, KD for T239S 
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and T239A are 0.37 µM and 0.20 µM, respectively. The KD of the substrate 
analogy-F-Tyr for wild type hIYD is 10 fold more than I-Tyr. Similar binding 
properties of F-Tyr were observed in T239S and T239A, KD for T239S and 
T239A are 3.3 µM and 1.5 µM, respectively. The equilibrium binding studies 
indicated that mutation of T239 to S or A has very little effect on the binding 
property of substrate. Substrate binding induces the conformational changes in the 
active site of wild type hIYD. Similar ligand binding property between wild type 
and mutants may imply a similar overall conformational change induced by 
substrate binding in mutants and wild type. The major difference in FMN 
coordination expected between wild type and mutant should be the loss of the N5 
H-bond due to the missing OH group in the T239A mutant. However, H-bonding 
may still possible if there is any H2O molecule appearing close enough to the N5 
atom of FMN.  
4.3.2 Crystal structure determination of hIYDT239A•F-Tyr 
To provide a clear picture of FMN coordination in hIYDT239A in the 
presence of ligand, the crystal structure of hIYDT239A•F-Tyr was solved. As 
shown in Figure 4-2, the overall structure of hIYDT239A•F-Tyr is very similar to 
the hIYD•I-Tyr (RMSD of 0.192 Å for a 405 atom comparison). F-Tyr binding 
induces the formation of the active site lid covering the FMN and F-Tyr. A close 
look at the F-Tyr binding site is shown in Figure 4-2B. All the conformations of 
the key residues that are critical for substrate binding, including Tyr161, Lys182, 
Glu157 and Ala130, are very similar in both structures (hIYDT239A•F-Tyr and 
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hIYD•I-Tyr). The Ala239 is far away from the ligand bound. Mutation Thr239 to 
Ala was shown to cause negligible effect on the structure of the binding site. This 
structural information is consistent with the binding affinity results of F-Tyr, in 
which both T239A mutant and wild type hIYD have similar KD (1.3 for wild type, 
3.3 for T239A). 
 
 
Figure 4-2. A) Structural compare of hIYDT239A•F-Tyr and hIYD•I-Tyr. B) 
Ligand binding environment in both hIYDT239A•F-Tyr and hIYD•I-Tyr. C) The 
omit map of Ala239, FMN and F-Tyr (2F0-Fc, contoured at 1 sigma). All the 
residues from hIYD•I-Tyr are in blue and purple. F-Tyr is in cyan. I-Tyr is in 





Figure 4-3 indicated the comparison of FMN coordination in 
hIYDT239A•F-Tyr with hIYD•I-Tyr. The notable difference in FMN 
coordination between them is the interactions between T239/A239 and FMN. As 
expected, mutation Thr239 to Ala239 eliminates the N5 H-bonding. Moreover, no 
electron density was detected in structure of hIYDT239A•F-Tyr that may 
represent a water molecule that could form H-bond with N5 atom of FMN. All the 
key residues that interact with FMN are superimposable in both structure, 
including the Ser 102 and 128, Arg 100, 101, 104 and 279.  
 
 
Figure 4-3. FMN coordination in hIYDT239A•F-Tyr and hIYD•I-Tyr. A) overlap 
the structures of hIYDT239A•F-Tyr and hIYD•I-Tyr. B) and C) show the close 
look at the FMN and residue 239 interaction. I-Tyr is in green, F-Tyr is in light 
blue, FMN from hIYDT239A•F-Tyr is in yellow and FMN from hIYD•I-Tyr is in 
gray. All the residues from hIYD•I-Tyr are shown in blue and purple. Residues 




4.3.3 Influence of mutation on redox property of FMN 
The crystal structure of hIYDT239A•F-Tyr indicated the loss of H-
bonding to N5 of FMN. To demonstrate the role of N5 H-bonding in redox 
control of hIYD, the redox property of FMN in T239S and T239A mutants in the 
presence and absence of F-Tyr were analyzed by xanthine/xanthine oxidase 
method as described previously.  
4.3.3.1 The redox properties of mutants in the absence of F-Tyr 
In the absence of F-Tyr, the oxidized FMN bound to both hIYDT239S and 
hIYDT239A have an absorbance maximum at 446 nm and a shoulder near 460 
nm (Appendices E). This absorbance decreased during reduction by xanthine and 
xanthine oxidase and ultimately generated a spectram consistent with the fully 
reduced FMNhq. The redox titration spectra of both mutants are very similar to the 
native hIYD as described in chapter 3. Only FMNox and FMNhq were detected 
during the titration of hIYDT239S and hIYDT239A, indicting a two-electron 
transfer process in the absence of F-Tyr (Appendices E). The redox potentials of 
the FMNox/hq were then measured to test if there is any change on the redox 
potential caused by mutation. The anthraquinone-2-sulfnate (AQS, -225mV) was 
selected as the reference dye for both mutants since AQS and FMN could be 
reduced simultaneously. The absorbance at 355 nm, an isosbestic point for AQS, 
was used for calculating the amount of the oxidized and reduced FMN. The 
absorbance at 330 nm and 328 nm, the isosbestic points for reduction of 
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hIYDT239S and hIYDT239A, respectively, were used for calculating the amount 
of the oxidized and reduced dye.  
 
 
Figure 4-4. Reduction of FMN bound to hIYDT239S and the reference dye AQS 
by xanthine/xanthine oxidase. Spectral changes were monitored every 2 min over 
a total of 120 min. Only a selected number of spectra are illustrated for clarity and 
the arrows indicate the direction of the absorbance change. The concentration of 
reduced AQS was measured at 330 nm, an isosbestic point for hIYDT239S, and 
conversely the concentration of reduced hIYD was measured at 355 nm, the 
isosbestic opint of AQS. Insert: the linear best fit of log(T239Sox/red) versus 
log(AQSox/red) was used to calculate the midpoint potential . 
 
As illustrated in figure 4-4, plot of log(T239Sox/red) versus log(AQSox/red) 
gave a slope of 1.03, indicating that T239S was reduced via a two-electron 
process by xanthine/xanthine oxidase. The midpoint potential calculated from this 
plot is – 206 mV. A plot of log(T239Aox/red) versus log(AQSox/red) gave a slope of 
0.92, indicating that T239A was also reduced via a two-electron process in the 
absence of substrate (Figure 4-5 ). The midpoint potential for T239Aox/red was 
calculated to be – 215 mV by method as described in Chapter 3. The midpoint 
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potential for T239S and T239A (– 215 mV) are similar to the wild-type enzyme 
hIYD (– 200 mV) (Table 4-3).  In the absence of substrate, the Em of wild-type 
hIYD, T239S and T239A mutants are all very close to the Eox/red of free FMN 
(pH 7, – 205 mV) in solution (79). This result is reasonable since the FMN 
binding site is open to the solvent in the absence of substrate. The distance 
between the OH side chain of Thr239 and the N5 of FMN ring was measured as 
4.8 Å, which doesn’t allow for H-bonding with N5. As a result, the mutation T to 




Figure 4-5. Reduction of hIYDT239A and the reference dye AQS by 
xanthine/xanthine oxidase. The concentration of reduced AQS was measured at 
328 nm and 355 nm, the isosbestic point for hIYDT239A and AQS, respectively. 
Insert: the linear best fit of log(T239Aox/red) versus log(AQSox/red) was used to 




4.3.3.2 Redox titration of T239S and T239A mutants in the presence of F-Tyr 
As described in Chapter 3, neutral semiquinone accumulated during the 
titration of wild type hIYD in the presence of F-Tyr. In contrast, no stable neutral 
semiquinone FMN could be detected during the reduction of T239A (Figure 4-6 
B). According to the structure of hIYDT239A•F-Tyr, mutation T239 to A causes  
 
 
Figure 4-6. Reduction of hIYD (A), hIYDT239A (B) and hIYDT239S (C) in the 
presence of F-Tyr by xanthine/xanthine oxidase. A spectral intermediate with a 
λmax of 590 nm was observed in reduction of both hIYDT239S and hIYD (red 
line-maximum accumulation). In contrast, this intermediate wasn’t observed in 




the loss of the OH side chain and its H-bond to N5 atom of FMN. The lack of 
neutral semiquinone observed in T239A mutant indicates that the H-bond 
between the OH side chain of T239 and N5 of FMN is very critical to the 
stabilization of the semiquinone.  
As shown in Figure 4-7, safranine O (SFO, -280 mV) was used as the 
reference dye to measure the redox potential of T239Aox/hq. The absorbance at 520 
nm, the maximum absorbance of SFO, and the absorbance at 445 nm after 
correcting for the SFO absorbance at 445 nm were used for calculating the 
amount of the SFO and FMN, respectively. A slope of 0.9 was obtained after 
plotting the log(T239AFMNox/red) versus log(SFOox/red), indicative of the two-
electron process for T239A oxidized FMN to hydroquinone FMN. The midpoint 
redox potential for T239AFMNox/hq was calculated to be – 272 mV.  
For hIYD T239S mutant (Figure 4-6 C), in the presence of F-Tyr, an 
absorption peak was observed at 590 nm regions, suggesting the formation of a 
neutral semiquinone species during the reduction. However, as indicated by the 
absorbance at 595 nm, the maximum accumulation of the semiquinone in the 
T239S mutant is 55 % compared to 99 % from FMNox to FMNsq for wild type 
hIYD. This difference may be caused by the missing methyl group, which alters 
the position of the OH side chain relative to N5 atom. T239S mutants may result 
in a weaker of hydrogen bond and a decrease in the stabilization of the 
semiquinone FMN. The redox potential of FMNox/sq for T239S mutants was close 
to the dye phenosafranine (PSF, – 259 mV). The absorbance at 494 nm, an 
isosbestic point for reduction of oxidized T239S to semiquinone T239S, was used 
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for calculating the amount of the dye PSF (Figure 4-8). The absorbance at 445 nm 
after correcting for the PSF absorbance at 445nm was used for calculating the 
amount of the oxidized FMN. The plot of log(T239SFMNox/sq) versus 
log(PSFox/red) should give a slop of 2 since oxidized FMN to semiquinone FMN is 
a one-electron process. However, a slope of 1.4 was found. The midpoint 
potential for T239AFMNox/sq was calculated to be – 234 mV, which is 80 mV 
lower than the wild type hIYDox/sq (–156 mV). The redox potential for the second 
phase FMNsq/hq in hIYDT239S wasn’t determined due to lack of obvious 




Figure 4-7. Reduction of hIYDT239A in the presence of F-Tyr and the dye SFO 
by xanthine/xanthine oxidase. Concentration of oxidized FMNox was measured at 
445 nm after correcting for the SFO absorbance. SFO concentration was 
measured at 520 nm. Insert: the linear best fit of log(T239AFMNox/red) versus 






Figure 4-8. Reduction of hIYDT239S in the presence of F-Tyr and the dye PSF 
by xanthine/xanthine oxidase. Concentration of oxidized FMNox was measured at 
445 nm after correcting for the PSF absorbance. PSF concentration was measured 
at 494 nm, an isosbestic point for reduction of oxidized FMN to semiquinone in 
T239S. Insert: the linear best fit of log(T239SFMNox/sq) versus log(PSFox/red) 
was used to calculate the midpoint potential. 
 
 
The redox titration of the mutant enzyme indicated that the N5 H-bond 
induced by ligand binding is very important for the redox property of hIYD. The 
mutant T239S exhibited a lower Eox/sq by 90 mV. Accumulation of semiquinone 
was still presented (55 % compared with 99 % for wild type). However, Mutant 
T239A significantly alters the redox property of Eox/sq and largely destabilizes the 
semiquinone. No semiquinone was observed for the reduction of T239A mutant. 
Similar N5 H-bonding had been reported in other flavoenzyme and also found 
critical for the stabilization of the semiquinone. For example, in the electron 
transfer protein from methylotrophic bacterium W3A1, the N5 of the FMN 
cofactor is hydrogen bonded to the side-chain OH group of Ser 254. A highly 
stabilized anionic flavin semiquinone was observed in oxidized W3A1 (78). 
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Mutations Ser254 to Thr, Cys and Ala were characterized to investigate the effect 
on the redox potential of FADox/sq. Replacing Ser254 with Thr decreased Eox/sq by 
90 mV. This difference may be caused by additional methyl group, which alter 
the position of the OH side chain relative to N5 atom. Ser254Cys and Ser254Ala 
mutants result in a weaker or absence of hydrogen bonding, decreased Eox/sq by 
105 mV and 120 mV, respectively, indicating that the N5 H-bonding is critical for 
establishing an high Eox/sq to stabilize the anionic semiquinone.  
4.3.4 Influence of an H-bond to FMN N5 on deiodination activity 
Redox titration indicated that mutation of Thr239 to Ala significantly 
affects the stabilization of the FMN semiquinone, which may also affect catalytic. 
To test this, the deiodination activities of T239S and T239A mutants of hIYD 
were determined (Appendices C) by radioactive assay as described in Chapter 2.  
The kinetic behavior of the hIYD T239S mutant is very similar to the wild 
type hIYD (Table 4-3). The KM of T239S is 17 µM for substrate I2-Tyr, which is 
slightly lower than the wild type 31µM. The kcat (12 min
-1





) of T239S are also very close to the kcat (12.5 min
-1





) of wild type. Mutation T239 to S has a slight effect on the deiodination 
process. The kinetics study on the T239A mutant indicates that T239A is still 
active. The KM of T239A is 50 µM for substrate I2-Tyr, which is slightly higher 





around ten-fold less than wild type hIYD. This result is very interesting and leads 
to an assumption that the semiquinone stabilization is important for the 
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deiodination process. Disabling the stabilization of the semiquinone could not 
completely disable the deiodination, however, could largely slow the process.  
4.4 Conclusion 
Substrate binding induced the formation of N5 H-bond from the OH side 
chain of Thr239 in hIYD. This H-bond is similar to one found in BluB. 
Otherwise, this type of H-bonding is very uncommon in nitro-FMN reductase 
family. The N5 H-bond in hIYD was assumed to be critical for the stabilization of 
the semiquinone. Mutations T239 to S and A were generated to alter or eliminate 
the N5-H bond of FMN. Structural analysis indicated that the mutant T239A 
successfully removed the N5 H-bond but kept all the other FMN interactions. 
Binding analysis indicated that elimination of N5 H-bond has a negligible effect 
on the binding of the ligands F-Tyr and I-Tyr. Redox analyses show that N5 H-
bond is very important for the stabilization of semiquinone. Mutant T239A was 
unable to stabilize the semiquinone. Kinetic study illustrated that the kcat/KM of 
T239A is 10 fold less than wild type, suggesting that stabilization of the 
semiquinone is important for the deiodination process of hIYD and providing 
more evident for the catalytic mechanism of hIYD through stepwise one-electron 





Chapter 5: Importance of the zwitterion region of I-Tyr for 
recognition and catalysis by hIYD 
5.1 Introduction 
In most flavoproteins, protein side chains and backbone provide direct 





edge of isoalloxazine is stabilized by H-bonds from backbone of Gly130 and 
Gly131, and side chains of Gln67, Tyr67 and Arg15 (49). In BluB, the closest 





are much less than FRP and involve only backbone of Ser167 and Leu108 and 




 edge coordination of FMN in hIYD is 
primary from the zwitterion region of substrate instead provided by residues of 
protein. As shown in Figure 5-1C, only Arg 104 is available to form a polar 
contact with the isoalloxazine ring of FMN at O2 in the absence of substrate. No 
polar contact to the N3O4 of the FMN ring was observed from the crystal 
structure of hIYD. In the presence of substrate (Figure 5-1), the carboxylate group 
of I-Tyr is H-bonding to N3 atom of FMN (distance is 2.9 Å).  Both the α-
ammonium and carboxylate groups of I-Tyr are able to form H-bonds to the O4 
atom (distance 2.8 Å and 3.5 Å). Thr239 also forms H-bond to the O4 atom of 
FMN.  
The role of N3 H-bonding at FMN for redox control is unclear though the 
N3 H-bonding is common in flavoproteins. Initially it was suggested that the 
primary function of N3 H-bond is to facilitate the FMN binding (101). Later 
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studies suggested that N3 H-bond contributed to the stabilization of the oxidized 
form FMN. Using N3 methyl derivatives precluding the N3 interactions, a lower 
midpoint potential for the oxidized to semiquinone couple was created (102). In 
the flavodoxin from Closteridium beijerinckii, the carboxylate group of Glu59 
serves as a hydrogen bond acceptor with the N(3)H of FMN. Mutagenesis of Glu 
to Gln and Ala significantly weakened the stablization of FMN semiquinone state 
and has modestly (<45 mV) perturbed the redox couple of FMN in flavodoxin 
(103). The direct interactions between the zwitterion region of I-Tyr and N3 of 
FMN in hIYD encouraged our investigation of the role of the N3 H-bond for the 
redox of FMN and catalysis of hIYD.  
I-Tyr binding induces the arrangement of three highly conserved residues 
of IYD homologs, Glu157, Tyr161 and Lys182 (Figure 5-1A hIYD), providing 
interactions to the zwitterion region of I-Tyr. The Glu157 forms H-bonds to both 
NH3
+
 (2.8 Å) and COO
-
 (3.4 Å) groups of substrate. Both Tyr161 and Lys182 
form H-bonds (distance between 2.6 to 2.9 Å) to the COO
-
 of I-Tyr.  Mutagenesis 
of these three amino acids (E153Q, Y157F and K178Q) in mIYD indicated that 
they are important for folding and catalysis. The K178Q mutant of mIYD was 
found insoluble and inactive. The Y157F and E153Q mutants were expressed in a 
soluble form. The Y157F weakened the binding of I-Tyr by 20 fold and decreased 
the kcat/KM value by 40 % (104). E153Q mutation abolished binding affinity of I-
Tyr and led to no detectable deiodination of I2-Tyr (104). The relationship of 
these residues to the catalysis might be realized through the H-bonding network 
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between these residues and the zwitterion region of substrate to stablize the active 
site lid.  
 
 
Figure 5-1. Interactions between the zwitterion region of I-Tyr and FMN in hIYD. 
A) H-bondings among I-Tyr, FMN and protein in hIYD·I-Tyr. B) I-Tyr binding 
caused arrangement of Glu157, Tyr161, Lys182, Arg104, Thr239 and FMN in 
hIYD. C) Interactions to issoalloxazine ring of FMN in the structure of hIYD in 
the absence of I-Tyr. In hIYD·I-Tyr, amino acids are in blue, FMN is in yellow 
and I-Tyr is in green. In hIYD, amino acids and FMN are all colored in gray. The 
zwitterion region of I-Tyr was shown as spheres in A. 
 
The role of the zwitterion region of I-Tyr for binding, redox and catalysis 
is evaluated in this chapter by using a number of substrate analogs with 
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substituents at the zwitterion region (Figure 5-2). 3-Iodotyrosinamide (I-
tyrosinamide) neutralizes the α-carboxyl group of I-Tyr but retains all other polar 
contacts to the protein and FMN. 3-Iodotyramine (I-tyramine) removes the COO
-
 
group from I-Tyr, precluding the H-bonding to Tyr161, Lys182 and N(3)H of 
FMN. 4-Hydroxy-3-iodophenyl propionic acid (I-HPPA), removes the NH3
+
 
group from I-Tyr, and disrupts the hydrogen bonding interactions to Glu157 and 
O4 atom of FMN. All the modified substrate analogs are expected to have 
negatively effect on IYD’s binding and catalysis. Moreover, to focus on the 
coordination instead of turnover influence on the redox, the fluoro-analogs were 
also generated to investigate the effects of modification on the redox of FMN.   
    




5.2 Materials and Methods 
5.2.1 Materials 
3-Iodotyrosinamide, 3-fluorotyrosinamide (F-tyrosinamide), 3-
iodotyramine, 3-fluorotyamine (F-tyramine), 4-hydroxy-3-iodophenyl propionic 
acid and 4-hydroxy-3-fluorophenyl propionic acid (F-HPPA) were synthesized by 
Dr. Fazel Fakhari, a post-doctoral associate in our group. All other reagents were 
obtained commercially at the highest grade available.   
5.2.2 General methods 
hIYD was expressed and purified according to the method described in 





after correcting for the contribution from bound FMN (A280/A450 = 1.57).  The 
ratio of FMN/hIYD monomer is 2. UV measurements were made with a Hewlett-
Packard 8453 spectrophotometer (Palo Alto, CA). Fluorescence data were 
obtained with a Horiba scientific fluoromax-4 spectrophotometer (Tokoyo, 
Japan). Analytic HPLC employed a reverse-phase Alltech C18 Econosphere 
semipreparative column with a flow rate of 1 mL/min. High-resolution mass 
spectra were determined with a Waters Acquity UPLC-MS (Xevo-G2).  
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5.2.3 Kinetic characterization of hIYD with I-Tyr and I-Tyr analogs by 
HPLC 
Catalytic deiodination of I-Tyr was measured by detecting formation of 
the deiodinated product by HPLC. The hIYD concentration was 0.08 µM and the 
reaction was performed at 25 °C with 500 mM NaCl and 100 mM sodium 
phosphate at pH 7.4. The concentration of I-Tyr was varied from 0 to 70 µM. 0.5 
% sodium dithionite was used as the reducing reagent for enzyme turnover. The 
total volume of the reaction mixture was 1 ml. The reaction was quenched by 
adding 10 µL formic acid. 
 The reaction solutions ( volume 1.01 ml) were then analyzed by a reverse-
phase HPLC using the following method: 0-10 min linear gradient from 0 to 5 % 
B, 25 min to 60 % B, 30 min to 95 % B, and another 10 min wash with 95 % B 
(buffer A- 0.1 % formic acid, buffer B-acetonitrile). Detection was carried out at 
280 nm. 40 µM m-cresol was included as an internal standard. Each assay was 
performed in duplicate and the average of their product formation was fit to 
Michaelis-Menten kinetics using Origin 7.0.  
The calibration curve of products was normalized by internal standard. 
The response factor (RF) of product Tyr with internal standard (m-creaol) is used 
to calculate the product formation by using the equation 5-1 (105) (Cx = 
concentration of the analyate, Cis = concentration of the internal standard, Ax = 
peak area of the analyate, Ais = peak area of the internal standard). 
Equation 5-1.                 RF = ((Ax)(Cis))/((Ais)(Cx))  
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Analysis of hIYD activity with the modified substrate followed the same 
procedures described above.  However, determinations of their initial rates were 
performed at concentrations equal to their KD. The hIYD concentration was 0.8 
µM and the reaction time was varied from 0 min to 5 hours to investigate the 
product formation vs time. After time-dependent analysis, the product peak was 
identified. The product was then analyzed by Mass Spec. To quantitate the 
amount of product, calibration curves normalized by the internal standard were 
created for each product with commercial tyrosinamide, tyramine or HPPA 
(concentration in the range of 5-80 µM) and the RF were obtained. The amount of 
product formation from the reaction mixture was determined by the RF and the 
peak area of every product as described above. All the reactions were repeated at 
least twice. The average of the two measurments was plotted as product formation 
vs time by Origin 7.0. The slop of the linear range of the progress curve 
represents the initial rate of hIYD. 
5.3 Results and Discussion 
5.3.1 Importance of the zwitterion region of I-Tyr for its binding affinity to 
hIYD 
The contributions of individual functional groups to the binding of the I-
Tyr were compared by determining the KD of modified substrate analogs by 
monitor fluorescence properties of bound FMN (Figure 5-3) and summarized in 
Table 5-1. The protein was found to precipitate under high ligand concentration. 
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Therefore, titrations were limited by the tolerance of the protein to ligands (~ 
1mM). All the data were collected before protein precipitation was observed.   
Modifications of the zwitterion tail of the ligands affected binding 
significantly (Table 5-1). Although I-tyrosinamide bound most tightly among I-
tyrosinamide, I-tyramine and I-HPPA, its KD is still 500-fold more than the native 
substrate I-Tyr. The effect of its CONH2 substitution might prevent the closing of 
the active cavity and the proper orientation of I-tyrosinamide to the isoalloxazine 
of FMN and Glu157, Tyr161 and Lys182.  
Once the NH3
+
 group from the I-Tyr is removed, the binding property of 
the subsequent derivative I-HPPA is also significantly impaired. The KD of I-
HPPA is 10-fold more than I-tyrosinamide and 5000-fold more than the native 
substrate I-Tyr. Removing the NH3
+
 group results a loss of H-bond to O4 of FMN 
and Glu157. The difference in the binding properties of I-HPPA and I-Tyr 
suggested the importance of the H-bonds from NH3
+






Figure 5-3. Equilibrium binding curves of hIYD with different ligands. Ligand 
binding was monitored by the change of fluorescence of FMN bound to IYD (4.5 
µM). The fluorescence intensities were normalized by dividing the initial 
fluorescence and plotted against ligand’s concentration. The measurement was 
repeated three times. The dissociation constants were obtained after nonlinear fit 
by Origin 7.0 as described in chapter 2. 
 
From the crystal structure of hIYD•I-Tyr, we observed that there are more 
H-bonds contacts to the COO
-
 group than NH3
+
 group. The COO
-
 group is H-
bonded to Glu157, Tyr161, Lys182 and N3 and O4 atom of FMN, whereas, the α-
ammonium group only has H-bonds to O4 and Glu157. Surprisingly, the binding 
affinity of compounds without a COO
-
 (I-tyramine) is 3 times tighter than 
compounds without a NH3
+
 group (I-HPPA). Perhaps the difference of KD 
between I-tyramine and I-HPPA indicates that the NH3
+
 group contributes more 
than the COO
-






Table 5-1. The binding properties of substrate analogs to hIYD. 
 





 0.15 ± 0.04  
I-tyrosinamide CONH2 NH3
+










 -- 1000 ± 120 
a
 














 -- >1000 
a
Error represents the standard deviation of KD from three independent 
measurements.  
 
Removing or altering the COO
-
 group and NH3
+
 groups alter the H-bonds 
network to the N3O4 edge of FMN and may result in a change in the redox 
property of FMN. To focus on the coordination effects on the redox of FMN 
rather than the subsequent catalysis, fluoro-analogs were used to measure the 
effect on the redox property of FMN in hIYD as described in chapter 3 and 4., 
Thus the binding affinities of the fluoro-analogs were necessary to envaluate the 
binding of the ligand with the active site for later redox titration characterization. 
As illustrated in Table 5-1, none of the fluoro-derivatives bound to IYD tightly. 
The strongest binding fluoro-substituation is F- tyrosinamide whose KD is more 
than 1 mM. For the F-tyramine and F-HPPA, the binding constants could not be 
obtained due to the limitation of protein’s tolerance to high concentrations of 
ligand (1 mM). No fluorescence quench for F-tyramine and F-HPPA observed 
88 
 
before the protein precipitated (Appendices F), indicating that the KD of F-
tyramine and F-HPPA must be higher than the KD of F-tyrosinamide.  
5.3.2 Zwitterion requirement for IYD catalysis 
All the activity assays were performed with a substrate concentration that 
equal to its KD to provide equal amount of active site occupancy. The reaction 
mixture was analyzed by HPLC and the product peak was identified by 
comparing the chromatogram of the reaction with the chromatogram of their 
mixture at 0 min, followed by UPLC/MS analysis.  
 
 
Figure 5-4. Analysis of hIYD’s activity with I-tyrosinamide by HPLC. A) 
Identification of product peak by comparing the chromatography at A280 of 
sample after 40 min catalysis with 0 min mixture. The product was identified with 
a retention time of 9.3 min. B) Progress curve of hIYD with I-tyrosinamide. 0.8 
μM hIYD was added to 80 μM I-tyrosinamide. All the experiment was repeated 
twice. Error in the figure represents the range. Linear analysis was performed in 




5.3.2.1 The activity of hIYD with I-tyrosinamide 
I-tyrosinamide exhibited the tightest binding to hIYD among all the 
modified compounds and was selected first for testing as a substrate for hIYD 
catalysis. As indicated in Figure 5-4, a new compound with a retention time of 9.3 
min was observed in the chromatography of the mixture (I-tyrosinamide, hIYD 
and dithionite) after 40 min incubation when compared to the chromatography of 
the same mixture with 0 min incubation. The peak area at 9.3 min was found to 
increase as the reaction time increased from 0 min to 60 min (Figure 5-4 B). This 
new species was likely the product of deiodination of I-tyrosinamide by hIYD. 
Considering the function of IYD as a dehalogenase, this product was assumed to 
be tyrosinamide. To test this, the chromatography of the commercial tyrosinamide 
was obtained. As we expected, the commercial tyrosinamide also show an A280 
peak at 9.3 min (Figure 5-4 A, black curve). The mass spectra of the fraction of 
9.3 min, revealed the most abundant peaks at m/z 136.08, as the tyrosinamide 
after fragmentation CONH2 (therotical m/z 136.07) (Figure 5-5 A). Standard 
tyrosinamide was also analyzed by LC/MS and was generated the same mass 
spectra as the product (Figure 5-5 B). Thus the product of the I-tyrosinamide after 
catalysis by hIYD was identified as tyrosinamide.  
To measure the initial rates of I-tyrosinamide catalyzed by hIYD, a 
progress curve of product formation was created as shown in Figure 5-4 B. The 
amount of product formation was calculated based on the observed peak area of 
product (9.3 min) and internal standard by using equation 5-1 and response factor 
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of 2.29 as observed from calibration analysis of tyrosinamide. The linear region of 
the reaction was observed within first 40 min. A slope of 0.057 (μM/min) was 
estimated form the linear region of the progress curve. The activity was 
performed under 0.8 μM hIYD. Therefore, the turnover number of IYD with I-






Figure 5-5. Mass spectra of product of I-tyrosinamide catalyzed by hIYD. A) 
Mass spectra of product fraction (9.3 min HPLC collection) of I-tyrosinamide 







Figure 5-6. Analysis of hIYD’s activity with I-tyramine by HPLC. A) 
Identification of product peak by comparing the chromatography at A280 of 2 
hour reaction mixture with the chromatography of substrate. The product was 
identified with a retention time of 10.2 min. B) Progress curve of hIYD with I-
tyramine. 0.8 μM hIYD was added to 400 μM I-tyramine. All the experiment was 
repeated twice. Error in the figure represents the range. Linear analysis was 
performed in Origin 7.0 for the 0 hour, 1 hour, 2 hour and 4 hour points. 
 
5.3.2.2 The activity of IYD with I- tyramine 
The catalytic activity of IYD with I-tyramine was also investigated under 
the condition that I-tyramine’s concentration equals to its KD value (400 µM). A 
new peak at 10.2 min was found to increase as the reaction time increased and as 
expected for a product. As shown in Figure 5-6 A, the retention time of this 
product (10.2 min) is close to the retention time of the commercial tyramine (9.8 
min). The slightly shift of the retention time may be caused by the dithionite in 
reaction sample. The UPLC/MS analysis of the 10.2 min fraction revealed the 
most abundant peaks at m/z 121.06, consistent with tyramine after fragmentation 
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NH2 (therotical m/z = 121.06) (Figure 5-7 A). The same mass spec pattern was 
found for the commercial tyramine (Figure 5-7 B). Thus, as expected, tyramine 
was the product of I-tyramine catalyzed by hIYD.  
 
 
Figure 5-7. Mass spectra of product of I-tyramine catalyzed by hIYD. A) Mass 
spectra of product fraction (HPLC collection, retention time = 10.2 min) of I-
tyramine catalyzed by hIYD. B) Mass spectra of commercial tyramine. 
 
A progress curve for the product of I-tyramine catalyzed by hIYD was 
performed with reaction times of 4 hours. The product formation was calculated 
based on the observed peak area of product (10.2 min) and internal standard by 
using equation 5-1 and response factor of 2.54 for tyramine with m-creasol. As 
shown in Figure 5-6 B, product formation is linear for the first 4 hours. A slope of 
2.17 was estimated form the linear region of the progress curve by Origin 7.0 and 
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Figure 5-8. Analysis of hIYD’s activity with I-HPPA by HPLC. A) Identification 
of product peak by comparing the chromatography at A280 of 2 hour reaction 
mixture with the chromatography of 0 min mixture. The product was identified 
with a retention time of 21.8 min. m-cresol is the internal standard. B) Progress 
curve of hIYD with I-tyramine. 0.8 μM hIYD was added to 1000 μM I-HPPA. All 
the experiment was repeated twice. Error in the figure represents the range. Linear 
analysis was performed in Origin 7.0 for reaction mixture with catalysis of 0 hour, 
1 hour, 2 hour and 3 hour points and 5 hour. 
 
5.3.2.3 The activity of hIYD with I- HPPA 
The activity of hIYD with I-HPPA was also analyzed at the concentration 
of I-HPPA equal to its KD (1000 µM). Mixture (I-HPPA, hIYD and dithionite) 
after 2 hours incubation was analyzed by HPLC. Comparing the chromatography 
of  the mixture with 2 hour incubation with chromatography of the same mixture 
with 0 min incubation, a peak area at 21.8 min was found to increase with the 
reaction time (Figure 5-8 A), and was expected to be the product of I-HPPA 
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catalyzed by hIYD. Commercial HPPA was analyzed under the same HPLC 
condition and exhibited a retention time at 21.4 min. The suggested product (21.8 
min fraction) was collected and analyzed by mass spec. The most abundant peak 
of the product was m/z 165.05, as the HPPA anion (therotical m/z = 165.06) 
(Figure 5-9 A). The same mass spec pattern was observed with the commercial 
HPPA (Figure 5-9 B). Based on the HPLC and LC/MS analysis, HPPA was 
identified as the product of I-HPPA after hIYD catalysis.  
 
 
Figure 5-9. Mass spectra of product of I-HPPA catalyzed by hIYD. A) Mass 
spectra analysis of expected product (HPLC collection of 21.8 min fraction) of I-
HPPA catalyzed by hIYD. B) Mass spectra of commercial HPPA. 
 
  
The progress curve of hIYD (0.8 μM) with I-HPPA (1000 μM) was 
generated to obtain the initial rate. The response factor of HPPA with m-creasol 
was observed as 2.14 after calibration analysis. The product formation was then 
calculated based on the observed peak area of product (21.8 min) and internal 
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standard by using equation 5-1. As shown in Figure 5-8 B, the product formation 
of I-HPPA deiodination is linear increase up to 5 hours. A slope of 1.41 was 
estimated form the linear region of the production formation curve by Origin 7.0 
and the rate of the hIYD catalysis under 1000 µM I-HPPA was measured as 1.76 
per hour. 
5.3.2.4 The kinetics parameter of IYD with native substrate I-Tyr 
The kinetic property of hIYD with native substrate (I-Tyr) under a 
concentration equal to its KD was characterized to provide a direct comparison to 
the catalytic property of hIYD with modified substrates. The binding of I-Tyr to 
hIYD is very tight, KD is 0.15 µM. Measuring the initial rate of deiodination at 
such low concentrations was not possible by the HPLC assay since the signal 
would be too low to be detected. The initial rate under 0.15 µM I-Tyr was 
extrapolated by creating the Michaelis-Menten curve over an I-Tyr concentration 
range of 5 µM to 60 µM. The amount of product under each [S] was calculated 
based on the response factor and the area of product and internal standard as 
described in method. For every [S] by using equation 5-1, the experiment was 
repeated twice. The average of the product formation was fitted into Michaelis-
Menten equation by Origin 7.0 (Figure 5-10). The KM and kcat of I-Tyr 
deiodination obtained from fitting analysis are 12 ± 2.5 µM and 7.3 ± 1.0 min
-1
, 
respectively. The kcat/KM (0.6 µM/min) of  I-Tyr from this HPLC analysis is very 
close to the kcat/KM of another native substrate I2-Tyr measured by radioactive 
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deiodination assay (0.4 µM/min). The initial rate of the hIYD catalysis with 0.15 
µM I-Tyr is estimated to be 4.9 hour 
-1
 from the Michaelis-Menten curve.  
 
 
Figure 5-10. Michaelis-Menten curve of I-Tyr deiodination by hIYD. Data points 
are an average of two repeats. Error is the range of data. Kinetic parameters were 
obtained after Michaelis-Menten analysis by Origin 7.0. The initial rate of I-Tyr 
deiodination at the concentration of I-Tyr equals to KD value (0.15 µM) was 
estimated from the curve. 
 









I-tyrosinamide 80 4.28 ± 0.04
a
 
I-tyramine 400 2.71 ± 0.03
a
 







Error represents the linear fitting error of the average of two repeats.. 
b
 Estimated from the Michaelis-Menten curve of hIYD with I-Tyr.  
 
5.3.2.5 Comparison of the catalytic rates of native and modified substrate.   
Table 5-2 summarized the deiodination rate of IYD with its native 
substrate I-Tyr and the modified substrates under [S] = KD. IYD deiodinated all 
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the modified iodo-ligands, and all of the rates are within one order of magnitude 
the rate of the native substrate I-Tyr. The rate of deiodination of I-HPPA is 2-fold 
less than the catalysis of I-Tyr. Considering the modification of zwitterion region 
caused at least 500 fold decrease in binding with IYD, the zwitterion region seems 
very critical for the affinity of ligand to IYD but not for activity. One possible 
explanation is that the zwitterion regions as well as the H-bond networks are very 
helpful for orienting the ligands in the active site but not directly involved in the 
catalytic process of IYD.  
 
 
Figure 5-11. Anaerobic reduction of hIYD in the presence of I-tyrosinamide by 
xanthine/xanthine oxidase. The absorbance at 445 nm was decrease while the 
absorbance around 590 nm was observed to increase during the reduction of hIYD 
in the presence of I-tyrosinamide. The absorptions at 446 nm later stop changing 






Figure 5-12. Selected spectra for the reduction of hIYD in the presence of F-
tyrosinamide by xanthine/xanthine oxidase. The reaction was monitored over 120 
min. The arrows indicate the direction of the changes in absorbance. Insert: A446 
vs A595 (A446 and A595 indicate the absorbance at 446 nm and 595 nm, 
respectively). 
 
5.3.3 Redox chemistry of IYD affected by the of H-bond interactions between 
the zwitterion region of substrates and N3 and O4 of the FMN ring 
To investigate the redox effect of the zwitterion interaction with FMN in 
hIYD, redox titrations were performed in the presence of I-tyrosinamide by 
xanthine/xanthine oxidase as described in chapter 2. As shown in Figure 5-11, a 
small absorbance peak was observed around 595-610 nm and was suggested as 
the neutral semiquinone peak. During the reduction of hIYD in the presence of I-
tyrosinamide, this 595 nm peak was found to increase in the beginning and last 
for 2 hours without decrease for doing turn over with enzyme. To focus on the 
coordination effects rather than the catalytic effects, 1 mM of F-tyrosinamide was 
added as the ligand to investigate the redox property of IYD. Again, a small A595 
peak was observed during the reduction of hIYD. Analysis the absorbance at 595 
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demonstrated that the absorbance first increase and then decrease indicating the 
FMN was first reduced to one-electron reduced semiquinone form and then 
reduced to two-electron reduced hydroquinone form (Figure 5-12). These 
observations are very similar to the observation of redox titration in the presence 
of F-Tyr with the native zwitterion region. F-Tyr binding induced the stabilization 
of semiquinone converts the reduction of hIYD to a stepwise single-electron 
transfer process. The observation of the semiquinone indicated that the F-
tyrosinamide is still able to convert the electron transfer of hIYD from a two-
electron to a stepwise single-electron process. The observed semiquinone in the 
presence of F-tyrosinamide is much less (20 % vs 99 %) than that observed for 




Figure 5-13. Reduction of hIYD in the presence of 1mM I-tyramine by 
xanthine/xanthine oxidase and monitored by UV/VIS. The data was recorded 




due to the poor binding affinity of the modified ligand or the change of the redox 
potential of the FMN in hIYD.  
 
Figure 5-14. Redox titration of hIYD in the presence of 1mM I-HPPA by 
xanthine/xanthine oxidase. The data was recorded every 2 min for over 120 min. 
The arrows indicate the direction of the changes in absorbance. 
 
The FMN Semiquinone was not detected during the redox titration of 
hIYD in the presence of 1 mM of I-tyramine and I-HPPA (2-fold KD of I-
tyramine, 1-fold KD of I-HPPA) (Figure 5-13 and 5-14). There are several 
possibilities regarding to this observation. First, the semiquinone signal may be 
too low to be detected due to the low active site occupancy at 1 mM of I-tyramine 
and I-HPPA. Second, H-bondings to the N3O4 edge might affect the redox of 
FMN since removing the H-bonding to the N3O4 edge results the semiquinone 
unable to be stabilized. Another possibility is related to the N5 H-bonding of the 




 group disrupted the interactions of substrate 
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with the key residues of the active site lid. As a result, the OH side chain of the 
Thr239 may be unable to move toward the N5 and H-bonding to the N5 of the 
isoalloxazine ring of FMN. Consequently, considering the critical role of N5 H-
bonding for stabilization of semiquinone in hIYD as descried in Chapter 4, the 
loss of the N5 H-bonding result in the loss of the ability of hIYD to stabilize the 
semiquinone FMN in the presence of modified substrate.  
5.4 Conclusion 
The zwitterion region of substrate makes direct contacts to the key residue 
of protein (Glu157, Tyr161 and Lys182) and the N3O4 edge of FMN. The role of 
this zwitterion region in binding, redox control and catalysis were investigated by 
using ligands with modified zwitterionic regions. This region was found critical 
for proper binding of the ligand to the active site of the enzyme. Altering the 
COO
-
 group to CONH2 or removing the COO
-
 group or NH3
+
 group caused at 
least a 500-fold decrease in binding affinity. hIYD was able to turn over all the 
modified ligands and release iodide from I-tyrosinamide, I-tyramine and I-HPPA. 
With equal occupancy to the active sites of hIYD, initial rates of deiodination of 
native and modified substrates were similar and within one order of magnitude, 
implying the zwitterion region of substrate is not critical for the catalysis of IYD. 
Modifications on the substrate certainly altered the H-bond network on the N3O4 
edge of FMN in IYD and might have contributed to the redox properties. 
Stabilized neutral semiquinone was observed during the redox titration of IYD in 
the presence of I-tyrosinamide and F-tyrosinamide, suggesting that these modified 
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substrates are still able to induce the stepwise single-electron transfer process for 
IYD’s catalysis. No semiquinone signal was detected by UV/VIS during titration 
of hIYD in the presence of 1 mM I-tyramine or 1mM I-HPPA. This observation 
either caused by the low occupancy of the enzyme active site or the change of the 




Chapter 6: Conclusion 
Despite the physiological importance of hIYD for thyroid hormon, hIYD 
remained poorly characterized. Previous discovery of the cDNA of hIYD allowed 
for limited expression of hIYD in HEK293. Characterization of hIYD was 
hampered by a lack of a convenient source of high quality active protein. Prior 
studies on mIYD indicated IYD consists of an N-terminal membrane domain, an 
intermediate domain and a catalytic domain that is common to the nitro-FMN 
reductase family. Removing the N-terminal domain previously allowed 
expression of soluble mIYD in insect cells (sf9) and more recently a sumo fusion 
of IYD allowed for heterologous expression in E.coli.  
The strategy of fusion to sumo and expression in E.coli has now been 
applied to hIYD and provide a large scale of highly pure hIYD (> 95 %, ~ 10 mg 
of hIYD per 1 L of culture). This provided sufficient quantities of hIYD for 
structural and mechanistic studies. Kinetics characterization indicated that the 
ability of hIYD to promote deiodination of I2-Tyr with similar kinetic parameters 
as homolenzymes from a wide range of organism. Crystallographic studies of 
hIYD indicated that the structure of hIYD and mIYD are nearly superimposable. 
Previous crystallographic studies with mIYD demonstrated that the substrate I-
Tyr coordinates directly to the isoalloxazine ring of FMN and induces closure of 
an active site lid. Similar interactions with the isoalloxazine ring are also induced 
by substrate in the structure of hIYD•I-Tyr, including the formation of H-bonds 




of the isoalloxazine 
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ring. The OH side chain of Thr239 moves close to the N
5 
of FMN and allows for 
an H-bond. After substrate binds, the aromatic ring of I-Tyr additionally stacks 
above the FMN. All the key residues (Thr239, Glu157, Tyr161 and Lys182) 
involved in these interactions are conserved in IYD homologs, implying their 
significance for catalysis.  
Consistent with previous proposals, IYD may promote catalysis through 
single electron transfer steps. In this thesis, accumulation of a neutral 
semiquinone FMN was observed during the reduction of hIYD in the presence of 
substrate. In the absence of substrate, only oxidized FMN and two-electron 
reduced FMN were observed during the reduction of hIYD by xanthine/xanthine 
oxidase. These observations indicate that substrate binding converts a two-
electron transfer process to a stepwise single-electron transfer process. The 
difference between the midpoint potentials of FMNox/sq and FMNsq/hq is 154 mV in 
the presence of F-Tyr; suggesting 99 % of FMN was reduced to FMNsq before 
further reduction. In contrast to the stabilization of the semiquinone, the 
hydroquinone was destabilized. The reduction of FMNsq to FMNhq in hIYD in the 
presence of F-Tyr was lowered to -310 mV versus -124 mV for free in solution. 
The ability of substrate to destabilize the FMNhq may facilitate its initial one 
electron reduction to initiate deiodination.  
The pH dependence of I2-Tyr binding with hIYD suggests that the phenolate 
form of substrate is the preferential form for IYD binding. Together with the 
observation of a semiquinone during redox titration, these findings improve our 
understanding about the catalytic mechamism and suggest that the phenolate form 
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of substrate binds to IYD, tautomerization to a keto intermediate and subsequent 
injection of a single electron into the carbonyl of the keto group to promote the 
deiodination process. However, fully understanding the catalytic mechanism of 
IYD awaits further investigation that is capable of trapping the keto intermediate.  
H-bonding to the isoalloxazine ring is crucial for redox control of many 
flavoproteins. Direct interaction between substrate and the isoalloxazine ring of 
FMN is rare in flavoproteins. Using hIYD as model, the investigation performed 
in this dissertation describes the significance of these interactions in stabilizing 
the active site lid, controlling the redox chemistry of FMN and promoting the 
catalysis. The N5 H-bonding between FMN and the OH side chain of Thr239 in 
hIYD was identified as the most important redox control of FMN among all the 
substrate induced interactions with FMN. Mutagenesis of Thr239 to Ala239 
removed the N5 H-bonding as confirmed by a crystal structure of hIYDT239A•F-
Tyr and no stable semiquinone was detected during the titration of T239A mutant 
in the presence of F-Tyr. Kinetic characterization of T239A with I2-Tyr illustrated 
that its kcat/KM is 10-fold lower than wild type, suggesting that the deiodination 
was affected by removing N5 H-bond of FMN.  
Moreover, the zwitterion region of substrate appeared to be critical for 
binding to IYD to stabilize the active site lid as indicated by the binding affinity 
of substrate analogs modified in their zwitterion region. Altering the COO
-
 to 




 group of I-Tyr caused at least a 500-fold 
decrease in binding affinity to hIYD. However, the interactions between this 
zwitterion region and FMN has little effects on the catalytic activity since all the 
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modified substrates exhibit similar initial rates of deiodination (within a order of 





A. Rate of deiodination of hIYD with I2-Tyr. 
The activity of hIYD with I2-Tyr was determined using the standard [
125
I]-
iodide release assays. Assays were performed in triplicate. The average of the 
three independent measurements was fit to the Michaelis-Menten equation using 
Origin 7.0. Error represents the standard derivation of three measurements. Red 
line was the fitting curve. The kinetic parameter obtained from fitting was a KM of 







B. Fluorescence titration assay to measure hIYD affinity for Tyr-derivatives. 
Ligand (I-Tyr, Cl-Tyr, Br-Tyr and F-Tyr) binding was monitored by the 
change of fluorescence (λex = 450 and λem = 527) of FMN bound to hIYD (4.5 
µM). The measurement was repeated three times. The average fluorescence 
intensities were normalized by dividing the initial fluorescence and plotted against 
ligand’s concentration. Error represents the standard derivation of three 
measurements. The dissociation constants were obtained after nonlinear fit by 





C. Rate of I2-Tyr deiodination of hIYDT239A and hIYDT239S 
Deiodinase activity of hIYDT239A (C-1) and hIYDT239S (C-2) with 
substrate I2-Tyr was determined using the standard [
125
I]-iodide release assays. 
The [hIYDT239A] = 0.4 μM. The [hIYDT239S] = 0.08μM. Assays were 
performed in triplicate. The average of the three independent measurements was 
fit to the Michaelis-Menten equation using Origin 7.0. Error represents the 







D. Fluorescence titration assay to measure hIYDT239S and hIYDT239A 
affinity for I-Tyr and F-Tyr.   
The binding of ligand I-Tyr (D-1) and F-Tyr (D-2) to hIYDT239S (4.5 
µM) and the binding of ligand I-Tyr (D-3) and F-Tyr (D-4) to hIYDT239A 
(4.5 µM) were monitored by the change of fluorescence (λex = 450 and λem = 
527) of FMN bound to protein. The measurement was repeated three times. 
The average fluorescence intensities were normalized by dividing the initial 
fluorescence and plotted against ligand’s concentration. The dissociation 
constants were obtained after nonlinear fit by Origin 7.0 as described in 
chapter 2. Error represents the standard derivation of three measurements. Red 









E. Selected spectra of reduction of hIYDT239A by xanthine/xanthine 
oxidase. 
Reduction of hIYDT239A by xanthine/xanthine oxidase as observed by 
UV/VIS.  Arrows at 446 nm indicate direction of absorption change during 






F. Fluorescence titration assay to measure hIYD affinity for fluoro-analogs 
 The binding of ligand F-tyrosinamide (F-1), F-tyramine (F-2) and F-
HPPA (F-3) to hIYD (4.5 µM) were monitored by the change of fluorescence 
(λex = 450 and λem = 527) of FMN bound to protein. For F-tyrosinamide, the 
measurement was repeated three times. The average fluorescence intensities 
were normalized by dividing the initial fluorescence and plotted against 
ligand’s concentration. The dissociation constants were obtained after 
nonlinear fit by Origin 7.0 as described in chapter 2. 
For F-tyramine and F-HPPA, The average fluorescence intensities of 
three repeats were normalized by dividing the initial fluorescence and plotted 
against ligand’s concentration. No fluorescence quenching was observed. The 
titration was limited by the tolerance of hIYD with high concentration of 
ligands (~ 1 mM). Error represents the standard derivation of three 
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